<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BRIGHT&#039;s Cerebral Palsy Cure Project &#187; Ambulatory cerebral palsy</title>
	<atom:link href="http://cpcure.com/tag/ambulatory-cerebral-palsy/feed/" rel="self" type="application/rss+xml" />
	<link>http://cpcure.com</link>
	<description>Leading the way for a Cerebral Palsy Cure</description>
	<lastBuildDate>Wed, 22 Apr 2026 15:38:37 +0000</lastBuildDate>
	<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>Cerebral Palsy Research- September 2012</title>
		<link>http://cpcure.com/cerebral-palsy-research-september-2012/</link>
		<comments>http://cpcure.com/cerebral-palsy-research-september-2012/#comments</comments>
		<pubDate>Mon, 03 Dec 2012 17:06:19 +0000</pubDate>
		<dc:creator><![CDATA[miamane]]></dc:creator>
				<category><![CDATA[Research Posts]]></category>
		<category><![CDATA[Ambulatory cerebral palsy]]></category>
		<category><![CDATA[cerebral palsy]]></category>
		<category><![CDATA[cord blood]]></category>
		<category><![CDATA[nuerodevelopmental disabilty]]></category>
		<category><![CDATA[Occuapational therapy for children with cerebral palsy]]></category>
		<category><![CDATA[physical therapy for cerebral palsy]]></category>
		<category><![CDATA[spastic paraplegia]]></category>
		<category><![CDATA[unilateral cerebral palsy]]></category>

		<guid isPermaLink="false">http://cpcure.com/?p=250</guid>
		<description><![CDATA[The Cerebral Palsy Alliance has compiled the attached list of the latest cerebral palsy research articles, as indexed in the NCBI PubMed (Medline) and Entrez (GenBank) databases for the week ending September 2012 1. Dev Med Child Neurol. 2012 Sep;54 Suppl 6:1-82. doi: 10.1111/j.1469-8749.2012.04386.x. Abstracts of the American Academy for Cerebral Palsy and Developmental Medicine]]></description>
				<content:encoded><![CDATA[<p><!--[if gte mso 9]><xml></p>
<p><o:shapedefaults v:ext="edit" spidmax="1026" /></p>
<p></xml><![endif]--><!--[if gte mso 9]><xml></p>
<p><o:shapelayout v:ext="edit"></p>
<p><o:idmap v:ext="edit" data="1" /></p>
<p></o:shapelayout></xml><![endif]-->The Cerebral Palsy Alliance has compiled the attached list of the latest cerebral palsy research articles, as indexed in the NCBI PubMed (Medline) and Entrez (GenBank) databases for the week ending September 2012</p>
<div class="WordSection1">
<p style="text-autospace: none;">
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">1. Dev Med Child Neurol. 2012 Sep;54 Suppl 6:1-82. doi: 10.1111/j.1469-8749.2012.04386.x.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Abstracts of the American Academy for Cerebral Palsy and Developmental Medicine 66th Annual Meeting.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">September 12-15, 2012. Toronto, Canada.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[No authors listed]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22925270 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - indexed for MEDLINE]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">2. Phys Occup Ther Pediatr. 2012 Sep 7. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Amount and Focus of Physical Therapy and Occupational Therapy for Young Children with Cerebral</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Palsy.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Palisano RJ, Begnoche DM, Chiarello LA, Bartlett DJ, McCoy SW, Chang HJ.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Physical Therapy and Rehabilitation Sciences, Drexel University , Philadelphia, Pennsylvania ,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">USA.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The aims of this study were to describe physical therapy (PT) and occupational therapy (OT) services for a cohort</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of 399 children with cerebral palsy (CP), 2-6 years old, residing in the United States and Canada. Parents</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">completed a services questionnaire by telephone interview. Therapists classified children&#8217;s Gross Motor Function</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Classification System (GMFCS) level. Mean minutes per month of PT and OT were greater for children receiving</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">services in both an educational and clinic setting. Mean minutes per month of PT and OT were greater for children</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">in levels IV-V than children in level I and greater for children in the United States than children in Canada. Parents</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">reported that interventions focused a moderate to great extent on primary impairments, secondary impairments,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">activity, and structured play activities, a moderate extent on environmental modifications and equipment; and a</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">moderate to small extent on self-care routines. The results support the importance of coordination of PT and OT</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">services.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22954372 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 12.0pt; font-family: 'Arial','sans-serif'; color: #333333;">September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: black;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: black;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 18.0pt; font-family: 'Arial','sans-serif'; color: #44973a;">Interventions and Management</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">Cerebral Palsy Alliance </span></strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">is delighted to bring you this free bulletin of the latest published research into cerebral</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">palsy. This special issue covers the month of September 2012.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">Our organisation is committed to supporting cerebral palsy research worldwide &#8211; through information,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">education, collaboration and funding. This free weekly bulletin is just one of our activities. Please find out more</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">at </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">www.cpresearch.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">Professor Nadia Badawi</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">Macquarie Group Foundation Chair of Cerebral Palsy</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #333333;">PO Box 560, Darlinghurst, New South Wales 2010 Australia</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">2</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">3. Disabil Rehabil. 2012 Aug 28. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">impact on muscle morphology and strength.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Williams SA, Elliott C, Valentine J, Gubbay A, Shipman P, Reid S.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">School of Sport Science, Exercise &amp; Health.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Purpose: Investigate the combination effects of strength training and Botulinum Toxin Type-A (BoNT-A) on muscle</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">strength and morphology in children with Cerebral Palsy (CP). Methods: Fifteen children receiving BoNT-A,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">classified as Spastic Diplegic CP, GMFCS I-II, and aged 5-12 years were recruited for this study. Randomly</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">allocated to 10 weeks of strength training either before or after BoNT-A, children were assessed over 6 months.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Eight of the 15 children also completed a control period. The Modified Ashworth Scale measured spasticity. The</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Goal Attainment Scale (GAS) assessed achievement of functional goals. Magnetic Resonance Imaging assessed</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">muscle volume (MV). Instrumented dynamometry assessed strength. Results: Spasticity was significantly reduced</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">following BoNT-A injection (p = 0.033). Children made significant isokinetic strength gains (mean p = 0.022, ES =</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">0.57) in the intervention period compared to the control period (mean p = 0.15, ES = 0.56). Irrespective of timing,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">significant strength improvements were seen immediately (10 weeks) and over 6 months for all children. This was</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">also the case for improvements in the GAS (immediately: mean p = 0.007, ES = 4.17, 6 months: mean p = 0.029,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">ES = 0.99), and improvements in MV in all assessed muscles. Conclusion: The simultaneous use of BoNT-A and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">strength training was successful in spasticity reduction, improving strength and achieving functional goals, over and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">above treatment with BoNT-A alone. Muscles targeted for BoNT-A injection should be included in strength training.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22928803 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">4. J Pediatr Orthop. 2012 Sep;32 Suppl 2:S182-6.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Management of Children With Ambulatory Cerebral Palsy: An Evidence-based Review. Commentary by</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Hugh Williamson Gait Laboratory Staff.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Thomason P, Rodda J, Sangeux M, Selber P, Kerr Graham.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">* Hugh Williamson Gait Laboratory, The Royal Children&#8217;s Hospital † Murdoch Childrens Research Institute,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Parkville ‡ Department of Paediatrics, The University of Melbourne, Carlton, Vic., Australia.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The evaluation of complex interventions, such as Single Event Multilevel Surgery (SEMLS) requires more than</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">randomized controlled trials. Rehabilitation following SEMLS is prolonged and the outcomes of interest may not be</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">apparent for 5 years or more after the surgery. We suggest long term, prospective cohort studies with objective</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">outcome measures be recognized as of equal importance to randomized controlled trials. The evidence in support</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of instrumented gait analysis (IGA) is also reviewed. We suggest that clinical levels of evidence are not an</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">appropriate method to evaluate a measurement tool. Specifically, IGA should be evaluated in terms of validity,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">reliability and cost effectiveness. We demonstrate that the use of IGA has improved medium and long term</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">outcomes in ambulant children with cerebral palsy in a center where IGA has been used routinely both for planning</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">SEMLS and for monitoring outcomes.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22890459 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">5. PLoS One. 2012;7(8):e40686. Epub 2012 Aug 16.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Transcriptional abnormalities of hamstring muscle contractures in children with cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Smith LR, Chambers HG, Subramaniam S, Lieber RL.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Bioengineering, University of California San Diego, La Jolla, California, United States of America.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Cerebral palsy (CP) is an upper motor neuron disease that results in a spectrum of movement disorders.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Secondary to the neurological lesion, muscles from patients with CP are often spastic and form debilitating</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">3</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">contractures that limit range of motion and joint function. With no genetic component, the pathology of skeletal</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">muscle in CP is a response to aberrant complex neurological input in ways that are not fully understood. This study</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">was designed to gain further understanding of the skeletal muscle response in CP using transcriptional profiling</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">correlated with functional measures to broadly investigate muscle adaptations leading to mechanical deficits.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Biospsies were obtained from both the gracilis and semitendinosus muscles from a cohort of patients with CP (n?=?</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">10) and typically developing patients (n?=?10) undergoing surgery. Biopsies were obtained to define the unique</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">expression profile of the contractures and passive mechanical testing was conducted to determine stiffness values</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">in previously published work. Affymetrix HG-U133A 2.0 chips (n?=?40) generated expression data, which was</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">validated for selected transcripts using quantitative real-time PCR. Chips were clustered based on their expression</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and those from patients with CP clustered separately. Significant genes were determined conservatively based on</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the overlap of three summarization algorithms (n?=?1,398). Significantly altered genes were analyzed for overrepresentation</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">among gene ontologies and muscle specific networks. The majority of altered transcripts were</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">related to increased extracellular matrix expression in CP and a decrease in metabolism and ubiquitin ligase</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">activity. The increase in extracellular matrix products was correlated with mechanical measures demonstrating the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">importance in disability. These data lay a framework for further studies and development of novel therapies.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22956992 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process] PMCID: PMC3431909</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">6. Int J Pediatr. 2012;2012:976425. Epub 2012 Aug 9.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">A systematic review of the clinimetric properties of habitual physical activity measures in young children</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with a motor disability.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Oftedal S, Bell KL, Mitchell LE, Davies PS, Ware RS, Boyd RN.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Queensland Cerebral Palsy &amp; Rehabilitation Research Centre, School of Medicine, The University of Queensland,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Brisbane, QLD 4029, Australia.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Aim. To identify and systematically review the clinimetric properties of habitual physical activity (HPA) measures in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">young children with a motor disability. Method. Five databases were searched for measures of HPA including:</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">children aged &lt;6.0 years with a neuromuscular disorder, physical activity defined as &#8220;bodily movement produced by</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">skeletal muscles causing caloric expenditure&#8221;, reported HPA as duration, frequency, intensity, mode or energy</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">expenditure, and evaluated clinimetric properties. The quality of papers was assessed using the COSMIN-checklist.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">A targeted search of identified measures found additional studies of typically developing young children (TDC).</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Results. Seven papers assessing four activity monitors met inclusion criteria. Four studies were of good</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">methodological quality. The Minimod had good ability to measure continuous walking but the demonstrated poor</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">ability to measure steps during free-living activities. The Intelligent Device for Energy Expenditure and Activity and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Ambulatory Monitoring Pod showed poor ability to measure activity during both continuous walking and free-living</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">activities. The StepWatch showed good ability to measure steps during continuous walking in TDC. Interpretation.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Studies assessing the clinimetric properties of measures of HPA in this population are urgently needed to allow</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">assessment of the relationship between HPA and health outcomes in this group.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22927865 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed] PMCID: PMC3423928</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">7. Disabil Rehabil. 2012 Sep 20. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Validity evidence of the Lateral Step Up (LSU) test for adolescents with spastic cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Chrysagis N, Skordilis EK, Tsiganos G, Koutsouki D.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Physical Education and Sport Sciences, Laboratory of Adapted Physical Activity/Developmental and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Physical Disabilities, National and Kapodistrian University of Athens , Greece.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Purpose: The present study examined the concurrent and construct validity of the Lateral Step Up (LSU) test, for</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">adolescents with CP. Method: A total of 35 adolescents, classified as GMFCS Levels I, II and III, were examined</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">using LSU, GMFM &#8211; 88 (D &amp; E), other functional mobility measures (TUG, STS, TUDS), body structures and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">functions (strength, ROM and spasticity). Results: LSU inter-correlations with: (i) GMFM &#8211; 88 (D &amp; E) (r = 0.656), (ii)</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">functional mobility measures (r = -0.567 to 0.721) and (iii) body structures and functions (r = 0.155 to 0.563) were at</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">4</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the appropriate range. The LSU differentiated adolescents with CP (F = 16.185, p = 0.000, η(2) = 0.503), according</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">to their GMFCS (I &gt; II, II &gt; III, I &gt; III). Finally, 50.27% of the LSU variability was explained by GMFCS differences,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with 65.7% of adolescents classified correctly across the three levels. Conclusions: The LSU may be perceived as</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">a valid instrument for assessing the functional mobility of adolescents with CP. [Box: see text].</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22991983 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">8. J Biomech. 2012 Sep 4. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">How much muscle strength is required to walk in a crouch gait?</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Steele KM, van der Krogt MM, Schwartz MH, Delp SL.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Mechanical Engineering, Stanford University, Stanford, CA, USA.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Muscle weakness is commonly cited as a cause of crouch gait in individuals with cerebral palsy; however,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">outcomes after strength training are variable and mechanisms by which muscle weakness may contribute to crouch</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">gait are unclear. Understanding how much muscle strength is required to walk in a crouch gait compared to an</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">unimpaired gait may provide insight into how muscle weakness contributes to crouch gait and assist in the design</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of strength training programs. The goal of this study was to examine how much muscle groups could be weakened</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">before crouch gait becomes impossible. To investigate this question, we first created muscle-driven simulations of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">gait for three typically developing children and six children with cerebral palsy who walked with varying degrees of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">crouch severity. We then simulated muscle weakness by systematically reducing the maximum isometric force of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">each muscle group until the simulation could no longer reproduce each subject&#8217;s gait. This analysis indicated that</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">moderate crouch gait required significantly more knee extensor strength than unimpaired gait. In contrast, moderate</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">crouch gait required significantly less hip abductor strength than unimpaired gait, and mild crouch gait required</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">significantly less ankle plantarflexor strength than unimpaired gait. The reduced strength required from the hip</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">abductors and ankle plantarflexors during crouch gait suggests that weakness of these muscle groups may</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">contribute to crouch gait and that these muscle groups are potential targets for strength training.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Elsevier Ltd. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22959837 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">9. Gait Posture. 2012 Aug 29. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Effect of fine wire electrode insertion on gait patterns in children with hemiplegic cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Krzak JJ, Corcos DM, Graf A, Smith P, Harris GF.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Shriners Hospitals for Children(®) &#8211; Chicago, 2211 North Oak Park Ave., Chicago, IL 60707, United States;</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Kinesiology and Nutrition, University of Illinois at Chicago, 1919 West Taylor, 650 AHSB (M/C 994),</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Chicago, IL 60612, United States.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">BACKGROUND: Fine wire electromyography (EMG) is commonly used for surgical decision making in equinovarus</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">foot deformity. However, this invasive technique may have the unwanted effect of altering the gait of children with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cerebral palsy (CP). The purpose of this study was to determine if fine wire insertion into the posterior tibialis</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">muscle affects temporal-spatial parameters and hindfoot kinematics during gait in children with equinovarus</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">secondary to hemiplegic CP. METHODS: 12 children with hemiplegic CP who presented with an equinovarus foot</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(mean age 12.5 yrs, four right-sided, eight left-sided) were recruited. Temporal-spatial parameters and 3-D</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">segmental foot and ankle kinematic gait data were collected utilizing standard gait analysis and the Milwaukee Foot</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Model (MFM). Three representative trials with and without fine wire electrode insertion were compared to determine</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the effect of electrode placement in the posterior tibialis on temporal spatial-parameters and hindfoot sagittal,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">coronal and transverse plane kinematic peaks, timing of kinematic peaks, and excursions. RESULTS: No significant</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">differences in any temporal-spatial or kinematic parameters were observed between &#8220;with wire&#8221; and &#8220;without wire&#8221;</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">conditions. Strong correlations were observed among the gait parameters, with the exception of cadence, for the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">two conditions. DISCUSSION: Fine wire insertion into the posterior tibialis had no measurable effect on the gait of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">individuals with equinovarus secondary to hemiplegic CP. This suggests that the simultaneous collection of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">5</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">segmental foot and ankle kinematics and fine wire EMG data of the posterior tibialis is acceptable for surgical</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">decision making in this patient population.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Elsevier B.V. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22939752 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">10. Gait Posture. 2012 Sep 5. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Prolonged swing phase rectus femoris activity is not associated with stiff-knee gait in children with</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cerebral palsy: A retrospective study of 407 limbs.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Knuppe AE, Bishop NA, Clark AJ, Alderink GJ, Barr KM, Miller AL.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Grand Valley State University, Cook DeVos Center for Health Sciences, 301 Michigan Street NE Suite 200 Grand</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Rapids, MI 49503, USA.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Prolonged swing phase rectus femoris (RF) activity has been implicated as a cause of stiff-knee gait (SKG) in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">children with cerebral palsy (CP) and continues to be cited as an indicator for RF intervention. The purpose of this</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">study was to determine what, if any, association exists between abnormal RF activity during preswing, initial swing</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and/or midswing and SKG in children with CP. This retrospective analysis involved three examiners independently</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">reviewing sagittal plane knee kinematic and RF surface electromyographic (EMG) data from 407 affected limbs of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">234 pediatric patients with CP. Five kinematic parameters were rated by each examiner as normal or pathologic:</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">peak knee flexion, knee range of motion during initial swing, total knee range of motion, peak knee flexion timing,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and rate of knee flexion. These ratings were used to classify each limb into one of three groups: SKG, Borderline</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">SKG, or Non-SKG. From a representative EMG tracing, RF activity was examined during: the first half of preswing,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the latter 2/3 of initial swing, and midswing. Chi-squared tests were used to determine if significant associations</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">existed between SKG and RF activation during these three subphases. There was no association between SKG</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and prolonged RF activity during the latter 2/3 of initial swing or during midswing. However, a significant relationship</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">between SKG and RF activity during the first half of preswing was found (p&lt;0.001). Neither prolonged RF activity</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">during initial swing, nor the presence of RF activity during midswing, were associated with SKG, thus refuting these</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">commonly held associations.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Elsevier B.V. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22959561 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">11. Dev Med Child Neurol. 2012 Aug 28. doi: 10.1111/j.1469-8749.2012.04419.x. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Functional electrical stimulation in children and adolescents with cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">VAN DER Linden M.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Queen Margaret University &#8211; Rehabilitation Sciences, Edinburgh, UK.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22924527 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">12. Orthop Traumatol Surg Res. 2012 Aug 30. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Neuro-orthopaedic evaluation of children and adolescents: A simplified algorithm.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Cottalorda J, Violas P, Seringe R; the French Society of Pediatric Orthopaedics.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Pediatric Orthopaedics Surgery, University Hospital of Montpellier, Lapeyronie Hospital, 371, avenue</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">du Doyen-Gaston-Giraud, 34295 Montpellier cedex 05, France.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Orthopaedic surgeons are often the first physicians to evaluate paediatric patients in the event of delayed walking,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">6</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">gait abnormalities, or parental concern about motor abilities. Therefore, orthopaedic surgeons must be thoroughly</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">familiar with the normal neurodevelopmental stages. Neurological disorders are often first recognised during an</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">orthopaedic evaluation. Minimal neurological abnormalities should be taken as warning signs that require additional</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">investigations. Consequently, the evaluation must follow a strict protocol, even in children referred for apparently</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">trivial functional disorders. We have developed an original physical examination protocol in which the largest</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">possible number of signs is sought in each body position to ensure that the examination is both systematic and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">rapid. About ten minutes are required when all findings are normal. This protocol is extremely helpful for identifying</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the cause of the problem that motivated the evaluation or for reassuring the child and family. The main causes of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">paediatric orthopaedic disorders are cerebral palsy, spinal dysraphism, myopathies, peripheral neuropathies, motor</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">neuron diseases, and intraspinal tumours. In some instances, no definitive diagnosis can be established clinically.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">In this situation, appropriate orthopaedic treatment can be initiated, although considerable caution is in order when</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">establishing the indications. The cause may be detected only much later, when the clinical manifestations become</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">more prominent.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012. Published by Elsevier Masson SAS.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22939865 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">13. Spine (Phila Pa 1976). 2012 Aug 24. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Growing Rods for the Treatment of Scoliosis in Children With Cerebral Palsy: A Critical Assessment.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">McElroy MJ, Sponseller PD, Dattilo JR, Thompson GH, Akbarnia BA, Shah SA, Snyder BD; the Growing Spine</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Study Group.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">From the * Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, Maryland the † Division</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of Pediatric Orthopaedic Surgery, Rainbow Babies and Children&#8217;s Hospital, Case Western Reserve University,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Cleveland, Ohio the § Department of Orthopaedic Surgery, University of California, San Diego, California the ¶ San</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Diego Center for Spinal Disorders, La Jolla, California the ** Nemours/Alfred I. DuPont Hospital for Children,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Wilmington, Delaware and the ‡ Department of Orthopaedic Surgery, Children&#8217;s Hospital Boston, Boston,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Massachusetts.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Study Design. Retrospective analysis.Objective. To evaluate, in children with cerebral palsy (CP), the following</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">aspects of growing rod (GR) treatment for scoliosis: structural effectiveness, effect of pelvic fixation, hospital stay</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">duration, and complications. Summary of Background Data. Children with CP frequently develop severe spinal</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">deformity and pelvic obliquity (PO). Growth-preserving strategies are attractive, but comorbidities raise the risk/</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">benefit ratio. To our knowledge, no previous studies have focused on growth-preserving spine surgery in these</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">children. Methods. From our multicenter patient group, we identified 27 children with CP treated with GRs (single</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">rod in 4; dual rods in 23 [15 extending to the pelvis]). We collected radiographic, surgical, hospital stay, and major</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">complication data. We compared Cobb angle and PO improvement between patients with and without pelvic</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">instrumentation via Student&#8217;s t test (significance, P = 0.05). No patient required anterior spinal fusion. Results.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Average improvements for all patients (preoperative to latest follow-up) were: Cobb angle, 35° ± 23°; PO, 14° ± 19°;</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">T1 to S1 length, 7.9 ± 4.4 cm; and space available for lung ratio, 0.17 ± 0.21. For the 8 patients who underwent</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">fusion, average improvements (preoperative to postfusion) were: Cobb angle, 43° ± 28°; PO, 2° ± 21°; T1 to S1</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">length, 9.5 ± 6.0 cm; and space available for lung ratio, 0.26 ± 0.28. Pelvic GR fixation produced better PO</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">correction (P &lt; 0.001) but similar Cobb angle correction (P = 0.556). Hospital stays averaged 8.7 ± 12.1 days after</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">initial surgery, 1.4 ± 2.5 days after lengthening (45% were outpatient procedures), and 13.4 ± 6.2 days after fusion.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The most common complication was deep wound infection (30%).Conclusion. GRs via a posterior-only approach</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">are effective. Constructs extending to the pelvis better control PO. However, 30% of patients experienced deep</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">wound infection.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22926278 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">7</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">14. J Pediatr Orthop. 2012 Sep;32 Suppl 2:S172-81.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Management of Children With Ambulatory Cerebral Palsy: An Evidence-based Review.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Narayanan UG.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">* Divisions of Orthopaedic Surgery &amp; Child Health Evaluative Sciences, The Hospital for Sick Children † Bloorview</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Research Institute, Holland Bloorview Kids Rehabilitation Hospital, University of Toronto, Toronto, ON, Canada.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">This article reviews the current best evidence for musculoskeletal interventions in children with ambulatory cerebral</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">palsy (CP). The effectiveness of interventions in CP must first consider what CP and its associated pathophysiology</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">are and take into account the heterogeneity and natural history of CP to put definitions of &#8220;effectiveness&#8221; into</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">perspective. This article reviews the current standards of the definition and classification of CP, discusses the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">natural history and specific goals for the management of ambulatory CP, as well as the outcome measures</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">available to measure these goals. The current best evidence of effectiveness is reviewed for specific interventions</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">in children with ambulatory CP including spasticity management with botulinum toxin A injections and selective</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">dorsal rhizotomy; multilevel orthopaedic surgery to address contractures and bony deformity; and the role of gait</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">analysis for surgical decision-making before orthopaedic surgery.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22890458 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">15. Acta Med Iran. 2012 Jul;50(7):463-7.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Late sequelae of hip septic arthritis in children.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Baghdadi T, Saberi S, Sobhani Eraghi A, Arabzadeh A, Mardookhpour S.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Orthopedic Surgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Septic arthritis of the hip in children has multiple sequelae and may result in severe disability. Significant morbidity</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">can be prevented by early recognition and treatment. The authors reviewed 13 children with 14 hips with sequelae</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of septic arthritis of the hip. All of children had history of hip septic arthritis before age of 4 years. Six were male</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">subjects, and 7 were female subjects. We evaluated the history, clinical findings and radiographs of all children who</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">had been treated at the Imam Khomeini hospital between 1986 and 2001 for septic arthritis of the hip. Final results</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of operations in patients include range of motion, presence or absence pain, joint stability, limb-length discrepancy</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">were assessed. Three hips had mild pain in usual daily activities and one patient with cerebral palsy experienced</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">hip instability. Most of patients (80%) had flexion contracture about 10-15 degrees . Final results showed average</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">limb length discrepancy was about 2.8 cm. Septic arthritis of the hip in children may result in a spectrum of residual</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">problems and the significant complications can be averted by early detection and treatment. Treatment in younger</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">age cause better outcome.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22930377 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">16. Dev Med Child Neurol. 2012 Aug 27. doi: 10.1111/j.1469-8749.2012.04401.x. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Acceptability and potential effectiveness of a foot drop stimulator in children and adolescents with cerebral</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">palsy.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Prosser LA, Curatalo LA, Alter KE, Damiano DL.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Center for Rehabilitation, The Children&#8217;s Hospital of Philadelphia, Philadelphia, PA; Functional &amp; Applied</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Biomechanics Section, Rehabilitation Medicine Department, National Institutes of Health Clinical Center, Bethesda,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">MD; Mount Washington Pediatric Hospital, Baltimore, MD, USA.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Aim: Ankle-foot orthoses are the standard of care for foot drop in cerebral palsy (CP), but may overly constrain</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">ankle movement and limit function in those with mild CP. Functional electrical stimulation (FES) may be a less</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">restrictive and more effective alternative, but has rarely been used in CP. The primary objective of this study was to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">conduct the first trial in CP examining the acceptability and clinical effectiveness of a novel, commercially available</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">8</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">device that delivers FES to stimulate ankle dorsiflexion. Method: Twenty-one individuals were enrolled (Gross</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Motor Function Classification System [GMFCS] levels I and II, mean age 13y 2mo). Gait analyses in FES and non-</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">FES conditions were performed at two walking speeds over a 4 month period of device use. Measures included</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">ankle kinematics and spatiotemporal variables. Differences between conditions were revealed using repeated</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">measures multivariate analyses of variance. Results: Nineteen individuals (nine females, 10 males; mean age 12y</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">11mo, range 7y 5mo to 19y 11mo; 11 at GMFCS level I, eight at level II) completed the FES intervention, with all</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">but one choosing to continue using FES beyond that phase. Average daily use was 5.6 hours (SD 2.3). Improved</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">dorsiflexion was observed during swing (mean and peak) and at foot-floor contact, with partial preservation of ankle</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">plantarflexion at toe-off when using the FES at self-selected and fast walking speeds. Gait speed was unchanged.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Interpretation: This FES device was well accepted and effective for foot drop in those with mild gait impairments</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">from CP.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">© The Authors. Developmental Medicine &amp; Child Neurology © 2012 Mac Keith Press.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22924431 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">17. J Pediatr Orthop B. 2012 Sep 16. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Percutaneous pelvic osteotomy and intertrochanteric varus shortening osteotomy in nonambulatory</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">GMFCS level IV and V cerebral palsy patients: preliminary report on 30 operated hips.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Canavese F, Gomez H, Kaelin A, Ceroni D, de Coulon G.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Pediatric Surgery, University Hospital Estaing, Clermont Ferrand, France bDepartment of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Traumatology, Posadas Hospital, Buenos Aires, Argentina cDepartment of Peditiatric Orthopedics, University</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Hospitals of Geneva, Geneva, Switzerland.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">This study evaluated the outcome of severe cerebral palsy patients (Gross Motor Function Classification System</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">level IV and V) treated by simultaneous percutaneous pelvic osteotomy and intertrochanteric varus shortening</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">osteotomy for hip subluxation or dislocation between 2002 and 2011. Twenty-four patients (30 hips) with an</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">average age of 9.4 years (5-16.5) were reviewed at a mean follow-up of 35.9 months (6-96). Percutaneous pelvic</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">osteotomy lasted on average 30 min/patient per side (25-40) and was always performed through a skin incision of 2</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">-3 cm. The migration percentage and acetabular angle were assessed on plain radiographs. The mean Reimers&#8217;</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">migration percentage improved from 67.1% (42-100) preoperatively to 7.7% (0-70) at the last follow-up and the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">mean acetabular angle improved from 31.8° (22-48) to 15.7° (5-27). Five patients presented complications: one</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">redislocation, one bone graft dislodgement, and three with avascular necrosis of the femoral head. This study</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">should be considered as a pilot study. These results indicate that this combined approach is an effective, reliable,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and minimally invasive alternative method for the treatment of spastic dislocated hips in severe cerebral palsy</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">patients with an outcome similar to standard techniques reported in the literature.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22990440 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">18. Pediatr Phys Ther. 2012 Winter;24(4):308-12.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Comparison of articulated and rigid ankle-foot orthoses in children with cerebral palsy: a systematic</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">review.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Neto HP, Grecco LA, Galli M, Oliveira CS.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Rehabilitation Sciences Department, Universidade Nove de Julho, São Paulo, Brazil (Drs Neto and Santos Oliveira</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and Ms Collange Grecco); Bioengineering Department, Politecnico di Milano, Milan, Italy (Dr Galli).</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">PURPOSE: The aim of this review was to compare the effects of rigid and articulated ankle-foot orthoses on gait in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">children with cerebral palsy (CP). METHOD: A systematic review was carried out in 4 databases. The papers</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">identified were evaluated on the basis of the following inclusion criteria: (1) design-controlled clinical trial; (2)</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">population-children and adolescents with CP; (3) intervention-rigid or articulated ankle-foot orthoses; and (4)</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">outcome-improved motor function and gait performance. RESULTS: Seven controlled studies comparing the effects</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of different ankle-foot orthoses were found. Studies achieved PEDro scores of 3 and 4 for methodological quality.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">9</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">CONCLUSION: There is evidence supporting the use of an articulated ankle-foot orthosis by children with CP,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">because of the improved function this type of orthosis provides. However, other studies point out the advantages of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">a rigid orthosis for children with greater impairment related to spasticity and contractures.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22965199 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">19. Pediatr Phys Ther. 2012 Winter;24(4):302-7.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Importance of orthotic subtalar alignment for development and gait of children with cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Carmick J.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Rocky Mountain University, Provo, Utah. The author is in Private Practice in Alamo, California.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">PURPOSE: This case report addresses the assumption that ankle and foot orthoses assist children with cerebral</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">palsy. KEY POINTS: Outcome research reports are not consistent. Clinical observations and research studies</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">suggest that inappropriate fit and design of orthoses may contribute to poor outcomes. In particular, problems occur</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">when the subtalar joint is out of alignment as children often compensate with unwanted movement patterns that</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">affect progress, development, and function. Four cases are presented to demonstrate problems that can occur</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">when ankle-foot or supramalleolar orthoses are not cast in subtalar neutral. CONCLUSION: Physical therapists can</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">use their clinical observation skills to evaluate the proper fit and alignment of orthoses for children with cerebral</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">palsy.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22965198 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">20. Dev Neurorehabil. 2012;15(3):202-8.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Validation of the relation between the type and amount of seating support provided and Level of Sitting</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Scale (LSS) scores for children with neuromotor disorders.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Field DA, Roxborough LA.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Therapy Department, Sunny Hill Health Centre for Children, Vancouver, BC, Canada. dfield@cw.bc.ca</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">OBJECTIVES: To assess the construct validity of the Level of Sitting Scale (LSS) by examining the relationship</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">between LSS scores and the type and amount of seating supports. METHODS: Secondary analysis of the data for</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">114 children ≤18 years, with neuromotor disorders who participated in a responsiveness study of the Seated</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Postural Control Measure. RESULTS: A significant inverse relationship (Spearman rho = -0.42, p &lt; 0.05) was found</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">between LSS scores and amount of seating support provided. Statistically significant differences were also</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">revealed between LSS levels of sitting ability (p &lt; 0.004) and pelvic, thigh, trunk and head seating components and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">type of seating system, using Kruskal-Wallis test. CONCLUSION: This study provides evidence of construct validity</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">for the LSS in use as a discriminative measure of sitting ability in children with neuromotor disorders. Further</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">validation is justified. Clinically intuitive associations between sitting ability and seating interventions were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">confirmed.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22582851 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - indexed for MEDLINE]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">21. Phys Ther. 2012 Sep 6. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The Impact of Body-Scaled Information on Reaching.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Huang HH, Fetters L, Ellis TD, Wagenaar RC.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">H. Huang, ScD, OT, Department of Occupational Therapy and Graduate Institute of Behavioral Sciences, Chang</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Gung University, Taoyuan, Taiwan; Department of Physical Therapy &amp; Athletic Training, College of Health and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Rehabilitation Sciences: Sargent, Boston University, Boston, Massachusetts; and Division of Biokinesiology &amp;</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Physical Therapy, University of Southern California, Los Angeles, California. Mailing address: Department of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Occupational Therapy and Graduate Institute of Behavioral Sciences, Chang Gung University, 259 Wen-Hwa 1st</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Rd, Kwei-Shan Tao-Yuan, Taiwan.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">BACKGROUND: Environmental and task modifications are powerful methods used to affect action in rehabilitation</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and are frequently used by therapists. OBJECTIVE: The purpose of this study was to examine and quantify the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">relationship between hand size (person characteristics) and object size (environmental characteristics) and the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">effect of this relationship on the emergent reaching patterns for typically developing children and adults. DESIGN:</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">This is a cross-sectional prospective study. METHODS: Seventeen children and 20 adults were included and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">required to reach and grasp ten pairs of different sizes of cubes. The dimensionless ratios were calculated by</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">dividing the cube size by the aperture between index finger and thumb to quantify emergent reach and grasp</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">patterns. A critical ratio was used to establish the shift from a one-handed to an exclusive two-handed reach</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">pattern. RESULTS: The results demonstrated no significant difference in the mean critical ratios between the two</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">groups. However, a two-handed reach was used more frequently than a one-handed reach at a significantly smaller</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">ratio for children in comparison to adults. LIMITATIONS: The relational metrics between the cube and hand is only</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">one contribution to the emergent reaching and grasping patterns. CONCLUSIONS: Children had more variability of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">reaching patterns than adults. A personal constraint such as experience, and a task constraint of accuracy may</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">account for the variability. The results encourage further research on body-scaled information for individuals with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">different personal constraints, e.g., children with cerebral palsy, and the impact of body-scaled information on</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">emergent actions.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22956428 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">22. Clin Rehabil. 2012 Sep 5. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Effect of therapist-based constraint-induced therapy at home on motor control, motor performance and</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">daily function in children with cerebral palsy: a randomized controlled study.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Chen CL, Kang LJ, Hong WH, Chen FC, Chen HC, Wu CY.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Objective: To determine the effect of therapist-based constraint-induced therapy at home on motor performance,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">daily function and reaching control for children with cerebral palsy. Design: A single-blinded, randomized controlled</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">trial. Subjects: Forty-seven children (23 boys; 24 girls) with unilateral cerebral palsy, aged 6-12 years, were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">randomized to constraint-induced therapy (n = 24) or traditional rehabilitation (n = 23).Interventions:Constraintinduced</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">therapy involved intensive functional training of the more affected arm while the less affected arm was</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">restrained. Traditional rehabilitation involved functional unilateral and bilateral arm training. Both groups received</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">individualized therapist-based interventions at home for 3.5-4 hours/day, two days a week for four weeks. Main</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">measures: Motor performance and daily function were measured by the Peabody Developmental Motor Scale,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Second Edition and the Pediatric Motor Activity Log. Reaching control was assessed by the kinematics of reaction</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">time, movement time, movement unit and peak velocity. Results: There were larger effects in favour of constraintinduced</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">therapy on motor performance, daily function, and some aspects of reaching control compared with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">traditional rehabilitation. Children receiving constraint-induced therapy demonstrated higher scores for Peabody</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Developmental Motor Scale, Second Edition &#8211; Grasping (pretest mean ± SD, 39.9 ± 3.1; posttest, 44.1 ± 2.8; P &lt;</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">0.001), Pediatric Motor Activity Log (pretest, 1.8 ± 0.3; posttest, 2.5 ± 0.3; P &lt; 0.001) and shorter reaction time,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">normalized movement time (P &lt; 0.001) and higher peak velocity (P = 0.004) of reaching movement. Conclusions:</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Constraint-induced therapy induced better grasping performance, daily function, and temporal and spatiotemporal</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">control of reaching in children with unilateral cerebral palsy than traditional rehabilitation.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22952304 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">23. Res Dev Disabil. 2012 Aug 30;34(1):183-197. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">How does brain activation differ in children with unilateral cerebral palsy compared to typically developing</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">children, during active and passive movements, and tactile stimulation? An fMRI study.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Van de Winckel A, Klingels K, Bruyninckx F, Wenderoth N, Peeters R, Sunaert S, Van Hecke W, De Cock P,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Eyssen M, De Weerdt W, Feys H.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, KU Leuven, Belgium.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The aim of the functional magnetic resonance imaging (fMRI) study was to investigate brain activation associated</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with active and passive movements, and tactile stimulation in 17 children with right-sided unilateral cerebral palsy</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(CP), compared to 19 typically developing children (TD). The active movements consisted of repetitive opening and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">closing of the hand. For passive movements, an MRI-compatible robot moved the finger up and down. Tactile</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">stimulation was provided by manually stroking the dorsal surface of the hand with a sponge cotton cloth. In both</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">groups, contralateral primary sensorimotor cortex activation (SM1) was seen for all tasks, as well as additional</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">contralateral primary somatosensory cortex (S1) activation for passive movements. Ipsilateral cerebellar activity</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">was observed in TD children during all tasks, but only during active movements in CP children. Of interest was</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">additional ipsilateral SM1 recruitment in CP during active movements as well as ipsilateral S1 activation during</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">passive movements and tactile stimulation. Another interesting new finding was the contralateral cerebellum</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">activation in both groups during different tasks, also in cerebellar areas not primarily linked to the sensorimotor</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">network. Active movements elicited significantly more brain activation in CP compared to TD children. In both</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">groups, active movements displayed significantly more brain activation compared to passive movements and tactile</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">stimulation.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Elsevier Ltd. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22940170 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">24. Disabil Rehabil. 2012 Sep 20. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Exploration of the relationship between the Manual Ability Classification System and hand-function</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">measures of capacity and performance.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Ohrvall AM, Krumlinde-Sundholm L, Eliasson AC.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Women&#8217;s and Children&#8217;s Health , Karolinska Institutet, Stockholm , Sweden.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Purpose: To further investigate the construct of Manual Ability Classification System (MACS) by evaluating the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">relationship between children&#8217;s designated MACS levels and their outcomes on two different tests of hand function,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">measuring capacity and performance, respectively. Another aim was to use the International Classification of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Functioning, Disability and Health-Child and Youth version (ICF-CY) as a framework to explore the uniqueness of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the assessments. Method: Ninety-one children with cerebral palsy in MACS levels I-V, aged 5-17 years (mean 9.8,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">SD 3.0) participated. Data were collected using MACS, ABILHAND-Kids and Box and Block Test. Results: A strong</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">association between MACS and ABILHAND-Kids (r(s) = -0.88, p &lt; 0.05) and MACS and Box and Block Test (r(s) =</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">-0.81, p &lt; 0.05) was demonstrated. Children&#8217;s performance differed significantly between the different MACS levels</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(ABILHAND-Kids F (4:86) = 103.86, p &lt; 0.001, Box and Block Test F (4:86) = 59.18, p &lt; 0.001). The content</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">comparison with ICF-CY, as a frame of reference, showed that these instruments capture fine hand use in the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">activity and participation component. The linking of the instruments to various ICF-CY categories demonstrated</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">conceptual differences between the instruments. MACS had the broadest representation of ICF-CY domains.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Conclusions: This study strengthens the construct, and thereby the validity, of MACS as a classification of children&#8217;s</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">hand function, expressed by the handling of objects in everyday activities in their daily environments. [Box: see</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">text].</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22992179 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">25. Dev Neurorehabil. 2012 Sep 4. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Studies comparing the efficacy of constraint-induced movement therapy and bimanual training in children</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with unilateral cerebral palsy: A systematic review.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Dong VA, Tung IH, Siu HW, Fong KN.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Rehabilitation Sciences, The Hong Kong Polytechnic University , Hong Kong , PR China.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Objective: To review studies comparing the efficacy of constraint-induced movement therapy (CIMT) and bimanual</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">training (BIT) in improving the hemiplegic arm functioning and overall functional performance for children with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">unilateral cerebral palsy (CP). Methods: Systematic searches of electronic databases, reference lists and journals</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">identified seven studies that met pre-determined inclusion criteria. These studies were analysed in terms of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">participants, treatment activities and regime, outcome measures and results of intervention. Results: Both CIMT</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and BIT produced similar improvements in the bimanual and unimanual capacities of the affected arm and overall</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">functional performance. Conclusions: CIMT yields more improvements in the unimanual capacity of the impaired</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">arm compared with BIT. A potential benefit of BIT is that participants may see more improvement in both bimanual</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">performance and self-determined overall life goals. A combination of CIMT and BIT could be an option on improving</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">arm function for children with unilateral CP in future.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22946588 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">26. J Pediatr Rehabil Med. 2012;5(2):117-24.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Modified constraint induced movement therapy enhanced by a neuro-development treatment-based</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">therapeutic handling protocol: two case studies.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Haynes MP, Phillips D.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">NDT Pediatric Therapy, Rockingham, NC 28379, USA. mhaynes@etinternet.net</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Modified Constraint Induced Movement Therapy (CIMT) and Neuro-Developmental Treatment (NDT) are both</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">intervention strategies that focus on active practice to optimize function. CIMT involves constraint of the less</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">involved upper extremity during function and NDT includes facilitation of optimal postural control and symmetry to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">enhance the ability to complete a given motor function. The purpose of this article is to describe an intervention</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">protocol for children with hemiplegia that integrates key NDT and CIMT principles. Two children participated in a</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">modified CIMT (mCIMT)/NDT program 2 hours a day for two months. The children wore a constraint on the less</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">involved arm and participated in guided play with early intervention members and parents. Play was individualized</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">to developmental level and incorporated principles of NDT. Function was measured pre- and post-intervention</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">using the PDMS-2, QUEST, ACQUIRE Therapy Motor Patterns, and ACQUIRE Functional Activities. Both children</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">demonstrated motor skill acquisition, improved quality of functional use, and increased frequency of bilateral hand</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">use. Parents found the protocol challenging but manageable in their daily routines. The inclusion of NDT principles</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">within a mCIMT protocol may be an effective intervention to maximize functional motor skill acquisition in children</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with hemiplegia. Additional research is warranted to support this intervention.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22699102 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - indexed for MEDLINE]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">27. Exp Brain Res. 2012 Sep 14. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The influence of spatial working memory on ipsilateral remembered proprioceptive matching in adults with</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Goble DJ, Aaron MB, Warschausky S, Kaufman JN, Hurvitz EA.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Sensory-Motor and Rehabilitative Technology Laboratory (SMaRTlab), School of Exercise and Nutritional Sciences,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">College of Health and Human Services, San Diego State University, 5500 Campanile Drive, San Diego, CA, 92182-</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">7251, USA, dgoble@mail.sdsu.edu.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Somatosensation is frequently impaired in individuals with Cerebral Palsy (CP). This includes the sense of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">proprioception, which is an important contributor to activities of daily living. One means of determining</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">proprioceptive deficits in CP has been use of an Ipsilateral Remembered (IR) position matching test. The IR test</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">requires participants to replicate, without vision, memorized joint/limb positions previously experienced by the same</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(i.e. ipsilateral) effector. Given the memory component inherent to this task, the present study sought to determine</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the extent to which IR proprioceptive matching might be influenced by known spatial working memory deficits.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Eleven adults with CP underwent IR elbow position matching, where blindfolded individuals were given either a</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">short (2 s) or long (15 s) duration to memorize the target elbow angle. A standard clinical measure of spatial</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">working memory (i.e. Corsi block-tapping task) was also administered. The results showed that the directional (i.e.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">constant) error produced across trials did not differ between the short and long target duration conditions. However,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">it was found that participants were significantly more consistent in their matches (i.e. had smaller variable errors)</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">when given more time to encode proprioceptive targets in the long duration condition. The benefit of having more</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">time was greatest for those individuals with the highest variable errors in the short target condition, and a significant</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">association was seen between improvements in variable error and greater performance on 4/5 spatial working</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">memory measures. These findings provide the best evidence to date that IR position matching tests are influenced</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">by spatial working memory.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22975865 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">28. Otol Neurotol. 2012 Oct;33(8):1347-52.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Pediatric cochlear implants: additional disabilities prevalence, risk factors, and effect on language</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">outcomes.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Birman CS, Elliott EJ, Gibson WP.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">* The Sydney Children&#8217;s Network (Westmead); † Sydney Medical School, The University of Sydney, Sydney; and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">‡ The Sydney Cochlear Implant Centre, New South Wales, Australia.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">OBJECTIVE: To determine the prevalence of additional disabilities in a pediatric cochlear population, to identify</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">medical and radiologic conditions associated with additional disabilities, and to identify the effect of additional</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">disabilities on speech perception and language at 12 months postoperatively. STUDY DESIGN: Retrospective case</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">review. SETTING: Tertiary referral center and cochlear implant program. PATIENTS: Records were reviewed for</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">children 0 to 16 years old inclusive, who had cochlear implant-related operations over a 12-month period.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">INTERVENTIONS: diagnostic and rehabilitative. MAIN OUTCOME MEASURES: Additional disabilities</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">prevalence; medical history and radiologic abnormalities; and the effect on Categories of Auditory Performance</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(CAP) score at 12 months postoperatively. RESULTS: Eighty-eight children having 96 operations were identified.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The overall prevalence of additional disabilities (including developmental delay, cerebral palsy, visual impairment,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">autism and attention deficit disorder) was 33%. The main conditions associated with additional disabilities were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">syndromes and chromosomal abnormalities (87%), jaundice (86%), prematurity (62%), cytomegalovirus (60%), and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">inner ear abnormalities including cochlea nerve hypoplasia or aplasia (75%) and semicircular canal anomalies</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(56%). At 12 months postoperatively, almost all (96%) of the children without additional disabilities had a CAP score</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of 5 or greater (speech), compared with 52% of children with additional disabilities. Children with developmental</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">delay had a median CAP score of 4, at 12 months compared with 6 for those without developmental delay.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">CONCLUSION: Additional disabilities are prevalent in approximately a third of pediatric cochlear implant patients.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Additional disabilities significantly affect the outcomes of cochlear implants.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22975903 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">29. NeuroRehabilitation. 2012 Jan 1;31(2):117-29.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Botulinum toxin use in neuro-rehabilitation to treat obstetrical plexus palsy and sialorrhea following</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">neurological diseases: A review.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Intiso D, Basciani M.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Neuro-Rehabilitation Unit, Scientific Institute, Hospital IRCCS &#8216;Casa Sollievo della Sofferenza&#8217;, San Giovanni</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Rotondo, Italy.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">In neuro-rehabilitation, botulinum toxin (BTX) as adjunct to other interventions can result in a useful therapeutic tool</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">treating disabled people. Other than spasticity, numerous motor and non motor disorders can complicate clinical</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">course and hamper rehabilitative process of neurological impaired patients. A review of BTX use in treating</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">muscular imbalance of children with obstetrical brachial plexus palsy and in reducing sialorrhea following</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">neurological diseases including amyotrophic lateral sclerosis (ASL), Parkinson disease and cerebral palsy (CP) is</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">provided. Clinicians have to face unique and difficult to treat clinical conditions such as ulcers, sores and abnormal</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">posture and movement disorders due to neurological affections. BTX effectiveness in treating some of these</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">conditions is also provided. Since, neurologically disabled subjects can show complex dysfunction, prior to initiating</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">BTX therapy, specific functional limitations, goals and expected outcomes of treatment should be evaluated and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">discussed with family and caregivers.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22951705 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">30. Dev Med Child Neurol. 2012 Sep 5. doi: 10.1111/j.1469-8749.2012.04370.x. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">neurodevelopmental disability: a systematic review</span></strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Rodwell K, Edwards P, Ware RS, Boyd R.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Queensland Paediatric Rehabilitation Service, The Royal Children&#8217;s Hospital, Herston, Brisbane; School of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Population Health, The University of Queensland, Brisbane; Queensland Cerebral Palsy and Rehabilitation</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Research Centre, School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Aim: The aim of this paper was to systematically review the efficacy and safety of botulinum toxin (BoNT) injections</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">to the salivary glands to treat drooling in children with cerebral palsy and neurodevelopmental disability. Method A</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">systematic search of The Cochrane Central Register of Controlled Trials, PubMed, CINAHL (Cumulative Index to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Nursing and Allied Health Literature), EMBASE, and the Physiotherapy Evidence Database (PEDro) was conducted</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(up to 1 October 2011). Data sources included published randomized controlled trials (RCTs) and prospective</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">studies. Results Sixteen studies met inclusion criteria. Three outcome measures support the effectiveness of BoNT</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">for drooling. One RCT found an almost 30% reduction in the impact of drooling on patients&#8217; lives, as measured by</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the Drooling Impact Scale (mean difference -27.45; 95% confidence interval [CI] -35.28 to -19.62). There were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">sufficient data to pool results on one outcome measure, the Drooling Frequency and Severity Scale, which supports</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">this result (mean difference -2.71; 95% CI -4.82 to -0.60; p&lt;0.001). There was a significant reduction in the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">observed number of bibs required per day. The incidence of adverse events ranged from 2 to 41%, but was</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">inconsistently reported. One trial was terminated early because of adverse events. Interpretation BoNT is an</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">effective, temporary treatment for sialorrhoea in children with cerebral palsy. Benefits need to be weighed against</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the potential for serious adverse events. More studies are needed to address the safety of BoNT and to compare</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">BoNT with other treatment options for drooling.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">© The Authors. Developmental Medicine &amp; Child Neurology © 2012 Mac Keith Press.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22946706 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">31. Br J Oral Maxillofac Surg. 2012 Aug 30. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Ultrasound-guided injection of botulinum toxin A into the submandibular gland in children and young</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">adults with sialorrhoea.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Gok G, Cox N, Bajwa J, Christodoulou D, Moody A, Howlett DC.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Oral and Maxillofacial Surgery, Eastbourne District General Hospital, Kings Drive, Eastbourne, East</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Sussex BN21 2UD, UK.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Hypersalivation is a common and distressing complaint in children with neuromuscular disorders such as cerebral</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">palsy. Complications associated with severe drooling include daily changes of clothing, perioral dermatitis, dental</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">problems, dehydration, and aspiration pneumonia, which potentially have a detrimental effect on the quality of life of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the patient and carer. In this paper we update our previous work to show the potential benefits of ultrasound-guided</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">injection of botulinum toxin A (BTX-A) into the submandibular gland and report on new patients and follow-up data</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">on the existing group.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">reserved.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22939893 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">32. J Acoust Soc Am. 2012 Sep;132(3):2089.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Second-formant locus patterns in dysarthric speech.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Kim H, Hasegawa-Johnson M.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Beckman Institute, University of Illinois at Urbana-Champaign, Urbana, IL 61801hkim17@illinois.edu.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Second-formant (F2) locus equations represent a linear relationship between F2 measured at the vowel onset</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">following stop release and F2 measured at the vowel midpoint in a consonant-vowel (CV) sequence. Prior research</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">has used the slope and intercept of locus equations as indices to coarticulation degree and the consonant&#8217;s place of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">articulation. This presentation addresses coarticulation degree and place of articulation contrasts in dysarthric</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">speech, by comparing locus equation measures for speakers with cerebral palsy and control speakers. Locus</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">equation data are extracted from the Universal Access Speech (Kim et al. 2008). The data consist of CV sequences</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with labial, alveolar, velar stops produced in the context of various vowels that differ in backness and thus in F2.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Results show that for alveolars and labials, slopes are less steep and intercepts are higher in dysarthric speech</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">compared to normal speech, indicating a reduced degree of coarticulation in CV transitions, while for front and back</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">velars, the opposite pattern is observed. In addition, a second-order locus equation analysis shows a reduced</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">separation especially between alveolars and front velars in dysarthric speech. Results will be discussed in relation</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">to the horizontal tongue body positions in CV transitions in dysarthric speech.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22979801 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">33. J Pediatr Gastroenterol Nutr. 2012 Sep 13. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Increased Prevalence of Antibodies Against Dietary Proteins In Children And Young Adults With Cerebral</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Palsy.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Stenberg R, Dahle C, Magnuson A, Hellberg D, Tysk C.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">* Department of Paediatrics, Centre for Rehabilitation Research, Örebro University Hospital, and School of Health</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and Medical Sciences, Örebro University, Örebro, Sweden † Clinical Immunology, Department of Clinical and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Experimental Medicine, Faculty of Health Sciences, Linköping University, and Department of Clinical Immunology</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and Transfusion Medicine, County Council of Östergötland, Linköping, Sweden ‡ Clinical Epidemiology and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Biostatistic Unit, Örebro University Hospital, Örebro, Sweden § Centre for Clinical Research, Falun, and</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Women&#8217;s and Children&#8217;s Health, Uppsala University, Uppsala, Sweden || Department of Medicine,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Division of Gastroenterology, Örebro University Hospital, and School of Health and Medical Sciences, Örebro</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">University, Örebro, Sweden.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">OBJECTIVES: Undernourishment is common in children with cerebral palsy (CP) but the reasons are unknown. We</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">previously reported elevated levels of immunoglobulin (Ig) A and IgG antibodies against gliadin (AGA) and tissue</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">transglutaminase (tTG) in 99 children and young adults with CP without characteristic findings of gluten enteropathy</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">in small bowel biopsies. Our aim was to perform a case-control study of IgG-antibodies against other dietary</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">antigens, AGA, anti-tTG and IgE-antibodies against wheat and gluten. METHODS: Sera from 99 CP-cases and 99</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">healthy, age- and sex-matched controls were analysed with fluorescence enzyme-linked immunosorbent assay</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(FEIA) for detection of IgG-antibodies against beta-lactoglobulin, casein, egg white, IgG- and IgA-AGA, IgA-anti-tTG</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and IgE antibodies against gluten and wheat. RESULTS: Compared with controls, the odds ratio (OR) in CP cases</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">for having elevated levels of IgG antibodies against beta-lactoglobulin was 17.0 (95% CI 2.3-128), against casein</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">11.0 (95% CI 2.6-46.8) and against egg white 7.0 (95% CI 1.6-30.8). The IgE-responses for wheat/gluten were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">generally low. The tetraplegic (TP) and dyskinetic (DK) CP-subtypes had significantly higher frequencies of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">elevated levels for all tested antibodies except IgG against egg white, and IgA-anti- tTG. A significantly lower weight</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">was seen in CP-cases with positive versus negative serology. CONCLUSION: Elevated levels of IgG against</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">dietary antigens were more frequent in the CP-group compared with controls, and particularly in the TP and DK CPsubtypes</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with the most severe neurologic handicap and undernourishment. Hypothetically, malnourishment may</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cause increased intestinal permeability and thus immunization against dietary antigens.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22983381 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">34. Spec Care Dentist. 2012 Sep;32(5):210-7. doi: 10.1111/j.1754-4505.2012.00267.x.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Integrated approach to outpatient dental treatment of a patient with cerebral palsy: a case report.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Katz CR.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Professor of Pediatric Dentistry, School of Dentistry of Pernambuco State University, Brazil Member of student</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">team in the Specialization Program on Special Care in Dentistry, Pernambuco State University, Brazil.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The large number of oral manifestations associated with motor disorders in patients with cerebral palsy (CP) makes</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the dentist an indispensable member of the multidisciplinary team caring for this population. This case report</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">presents an 11-year-old girl with spastic CP who had severe motor impairment, and a description of her care</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">illustrates the importance of integrated care for patients with CP who are receiving outpatient dental treatment. It</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">was determined that the use of adaptations based on knowledge of CP supported the outpatient dental treatment.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The integrated approach used during dental treatment enabled the application of knowledge from the fields of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">dentistry, physical therapy, and speech therapy to provide for a better quality of life for the patient and,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">consequently, the caregiver through the improvement in the patient&#8217;s oral and general health.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">© 2012 Special Care Dentistry Association and Wiley Periodicals, Inc.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22943774 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">35. J Adolesc Health. 2012 Sep;51(3):272-8. Epub 2012 Mar 3.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Assessing the health, functional characteristics, and health needs of youth attending a noncategorical</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">transition support program.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Woodward JF, Swigonski NL, Ciccarelli MR.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, Indiana.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">PURPOSE: To assess the health, functional characteristics, and health care service needs of youth and young</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">adults with special health care needs attending a comprehensive, noncategorical transition program. METHODS: A</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">self-administered survey was developed from national health surveys and clinical experience to assess concepts</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">identified as important for successful transition to adulthood. Surveys were mailed to 198 parents of youth and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">young adults with special health care needs attending the transition clinic. Parents were asked about the youth&#8217;s</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">health, functional status, and health care services needed. The clinical database provided demographic and patient</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">health characteristics. Results were compared against the 2005-2006 National Survey of Children with Special</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Health Care Needs. RESULTS: Forty-four percent of surveys were returned. Average age of youth was 17.5 (11-</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">22) years old and diagnoses included cerebral palsy (36%), spina bifida (10%), developmental delay or Down</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">syndrome (17%), and autism (6%). Most youth needed assistance with personal care (69%) and routine needs</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(91%) and used assistive devices (59%). Compared with the 2005-2006 National Survey of Children with Special</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Health Care Needs, parents reported higher needs for all services except mental health care and tobacco or</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">substance use counseling. Forty three percent reported at least one unmet health need. Few parents reported the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">need for counseling on substance use (1%), sexual health screening (16%), nutrition (34%), and exercise (41%).</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">CONCLUSIONS: Youth attending our transition program had more functional limitations, poorer reported health</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">status, different diagnosis distribution, and higher levels of needed health services. Few parents identified needs for</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">other recommended adolescent preventive services. Transition programs should assess patient health</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">characteristics and service needs to design effective patient-centered services.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22921138 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">36. J Pediatr Urol. 2012 Aug 21. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Relationship of bladder dysfunction with upper urinary tract deterioration in cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Gündogdu G, Kömür M, Avlan D, Sari FB, Delibas A, Tasdelen B, Nayci A, Okuyaz C.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Pediatric Surgery, Bezmialem Vakif University, Medical Faculty, Department of Pediatric Surgery, Division of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Pediatric Urology, Istanbul 34093, Turkey.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Although lower urinary tract dysfunction (LUTD) in patients with cerebral palsy (CP) has been previously</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">documented by clinical observations and urodynamic tests, its correlation with upper urinary tract deterioration</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(UUTD) has not been demonstrated. This paper documents symptoms and urodynamic findings of LUTD and their</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">relationship with UUTD in 33 children with CP. By sonography, 4 of these children were found to have UUTD. Age</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">was found to correlate with UUTD, but gender difference and mental or motor functions did not. When comparing</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">urinary symptoms with UUTD, incontinence (n = 31) did not correlate, but on the other hand symptoms of detrusor</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">sphincter dyssynergia (interrupted voiding, urinary retention, hesitancy; n = 5) and culture proven febrile urinary</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">tract infections (n = 4) did. Abnormal urodynamics findings were not diagnostic. We conclude that, apart from</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">incontinence, dysfunctional voiding symptoms and febrile urinary tract infections are valuable indicators of UUTD.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22921013 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">37. J Thorac Cardiovasc Surg. 2012 Sep 6. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Clinical outcome score predicts the need for neurodevelopmental intervention after infant heart surgery.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Mackie AS, Alton GY, Dinu IA, Joffe AR, Roth SJ, Newburger JW, Robertson CM.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada; School of Public Health, University of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Alberta, Edmonton, Alberta, Canada; Stollery Children&#8217;s Hospital, Edmonton, Alberta, Canada.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">OBJECTIVE: Our goal was to determine if a clinical outcome score derived from early postoperative events is</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">associated with 18- to 24-month Psychomotor Developmental Index (PDI) score among infants undergoing</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cardiopulmonary bypass surgery. METHODS: We included infants aged =6 weeks who underwent surgery during</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">2002-2006, all of whom were referred for neurodevelopmental evaluation at age 18 to 24 months. We excluded</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">children with chromosomal abnormalities, hearing loss, cerebral palsy, or a Bayley III assessment. The prespecified</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">clinical outcome score had a range of 0 to 7. Lower scores indicated a more rapid postoperative recovery. Patients</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">requiring extracorporeal membrane oxygenation were assigned a score of 7. RESULTS: Ninety-nine subjects were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">included. Surgical procedures were arterial switch (n = 36), Norwood (n = 26), repair of total anomalous pulmonary</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">venous connection (n = 16), and other (n = 21). Four subjects had postoperative extracorporeal membrane</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">oxygenation. Clinical outcome scores were highest in the Norwood group (mean 4.1 ± 1.4) compared with the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">arterial switch group (1.9 ± 1.6) (P &lt; .001), total anomalous pulmonary venous connection group (1.6 ± 2.0) (P</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">&lt; .001), and other group (3.3 ± 1.6, P = not significant). A mean decrease in PDI of 10.9 points (95% confidence</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">interval, 4.9-16.9; P = .0005) was observed among children who had a clinical outcome score =3, compared with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">those with a clinical outcome score &lt;3. Time until lactate =2.0 mmol/L increased with increasing clinical outcome</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">score (P = .0003), as did highest 24-hour inotrope score (P &lt; .0001). CONCLUSIONS: Clinical outcome scores of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">=3 were associated with a significantly lower PDI at age 18 to 24 months. This score may be valuable as an end</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">point when evaluating novel potential therapies for this high-risk population.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22959319 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">38. Scand J Caring Sci. 2012 Aug 24. doi: 10.1111/j.1471-6712.2012.01071.x. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Psychological distress and perceived support among Jordanian parents living with a child with cerebral</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">palsy: a cross-sectional study.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Al-Gamal E, Long T.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Faculty of Nursing, The University of Jordan, Amman, Jordan School of Nursing, Midwifery &amp; Social Work,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">University of Salford, Salford, UK.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Background: Cerebral palsy, with a prevalence in Europe of 2-2.5 per 1000 live births, is the most common severe</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">physical disability affecting children. While many parents have positive perceptions of their disabled children, caring</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">for a child with disability can be exhausting and stressful, and social support is an important coping resource. There</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">is little evidence about how having a child with cerebral palsy affects Jordanian parents. Aim: The purpose of this</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">study was to provide insight into the psychological distress and perceived support among Jordanian parents living</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with a child with cerebral palsy. Method: In 2010, a cross-sectional, descriptive, correlational design was used with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">a nonprobability sample of 204 Jordanian parents. Both mothers and fathers, interviewed individually rather than in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">pairs, were recruited from health care centres that provided comprehensive care for children with cerebral palsy in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Jordan and from designated schools for special education. The Gross Motor Function Classification System, the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Perceived Stress Scale (PSS), the Beck Depression Inventory, the Strengths and Difficulties Questionnaire and the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Multidimensional Scale of Perceived Social Support (MSPSS) were administered to parents. Descriptive statistical</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">analysis was applied. Bivariate correlation analysis was undertaken to examine the relationship between variables.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Results: More than 60% of parents often felt nervous and stressed. The mean score on the PSS was 27.0 (SD =</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">9.33), and the mean score on the MSPSS was 58.9 (SD = 15.1). Severe disability in the child was associated with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">high mental distress in the parent and linked to low support from friends. There was a significant negative</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">correlation between parental stress, depression and social support. Parents with the most psychological distress</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">were the least well supported. Conclusion: This study has implications for health professionals in terms of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">developing strategies for reducing parental stress. There are implications for policy to provide support for parents</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and to develop family-centred services. The findings will inform an intervention study to investigate multiprofessional</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">support.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">© 2012 The Authors. Scandinavian Journal of Caring Sciences © 2012 Nordic College of Caring Science.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22924549 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">39. Res Dev Disabil. 2012 Sep 15;34(1):344-352. doi: 10.1016/j.ridd.2012.08.018. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Description and psychometric properties of the CP QOL-Teen: A quality of life questionnaire for</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">adolescents with cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Davis E, Mackinnon A, Davern M, Boyd R, Bohanna I, Waters E, Graham HK, Reid S, Reddihough D.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Jack Brockhoff Child Health and Wellbeing Program, McCaughey Centre, University of Melbourne, Melbourne,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Victoria, Australia. Electronic address: eda@unimelb.edu.au.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">To assess the measurement properties of a new QOL instrument, the Cerebral Palsy Quality of Life Questionnaire-</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Teen (CP QOL-Teen), in adolescents with cerebral palsy (CP) aged 13-18 years, examining domain structure,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">reliability, validity and adolescent-caregiver concordance. Based on age, 695 eligible families were invited to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">participate by mail. Questionnaires were returned by 112 primary caregivers (71.8% of questionnaires sent). 87</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">adolescents aged 12-18 years also completed the questionnaires. CP QOL-Teen, generic QOL instruments</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(KIDSCREEN, Pediatric Quality of Life Inventory), functioning (Gross Motor Function Classification System) and a</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">condition-specific instrument (PedsQL-CP) were used. Principal components analysis produced seven scales:</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">wellbeing and participation; communication and physical health; school wellbeing; social wellbeing; access to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">services; family health; feelings about functioning. Cronbach&#8217;s alphas for the derived scales ranged from 0.81 to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">0.96 (primary caregiver report) and 0.78 to 0.95 (adolescent report). Test-retest reliability (4 weeks) ranged from</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">0.57 to 0.88 for adolescent self-report and 0.29 to 0.83 for primary caregiver report. Moderate correlations were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">observed with other generic and condition specific measures of QOL, indicating adequate construct validity.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Moderate correlations were observed between adolescent self-report and primary caregiver proxy report. This study</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">demonstrates acceptable psychometric properties of both the adolescent self-report and the primary caregiver</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">proxy report versions of the CP QOL-Teen.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Elsevier Ltd. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22989577 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">40. Res Dev Disabil. 2012 Sep 15;34(1):266-275. doi: 10.1016/j.ridd.2012.08.017. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Patterns and predictors of participation in leisure activities outside of school in children and adolescents</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with Cerebral Palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Longo E, Badia M, Orgaz BM.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">INICO, Faculty of Psychology, University of Salamanca, Spanish Agency of International Cooperation &#8211; MAEC -</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">AECID, Avda. de la Merced, 109-131, 37005 Salamanca, Spain.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">This study analyzed the patterns and predictors of participation in leisure activities outside of school of Spanish</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">children and adolescents with Cerebral Palsy (CP). Children and adolescents with CP (n=199; 113 males and 86</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">females) participated in this cross-sectional study. Their mean age was 12.11 years (SD=3.02; range 8-18 years),</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and they were evaluated using the Spanish version of the Children&#8217;s Assessment of Participation and Enjoyment</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(CAPE). Means, standard deviations and percentages were used to characterize the profile of participation, and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">linear regression analyses were employed to assess associations between the variables (child, family and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">environmental factors) and the diversity, intensity and enjoyment of participation. Children and adolescents with CP</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">reported low diversity and intensity of participation and high levels of enjoyment. Participation in leisure activities</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">outside of school was determined more by child and environmental factors than by family ones.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Elsevier Ltd. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22989575 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">41. Res Dev Disabil. 2012 Aug 29;34(1):157-167. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Physical activity in a total population of children and adolescents with cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Lauruschkus K, Westbom L, Hallström I, Wagner P, Nordmark E.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Health Sciences, Faculty of Medicine, Lund University, Sweden.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The aims of this study were to describe the participation in physical activity of children with cerebral palsy (CP) at</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">school and during leisure time and to identify characteristics associated with physical activity. The frequency of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">receiving physiotherapeutic interventions were described as a variable of interest. A total population of 364 children</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with verified CP aged 7-17 years living in the Skåne region in Sweden was studied using cross-sectional data from</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the CP follow-up programme (CPUP). Proportional odds ratios showed the most severe gross motor limitations</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Gross Motor Function Classification System Expanded and Revised (GMFCS-E&amp;R) to be a characteristic for low</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">participation in physical education at school (PE) and GMFCS-E&amp;R level III to be a characteristic for low</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">participation in regular physical leisure activity. The age group of 7-11 years and obesity were characteristics</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">associated with high participation in PE, whereas thinness was associated with low participation in regular physical</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">leisure time activities. The highest proportion of children receiving physiotherapeutic interventions was found in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">GMFCS-E&amp;R level III, while mental retardation, especially if moderate or severe, proved to be an independent</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">characteristic associated with low frequency of physiotherapeutic interventions. Gender and epilepsy did not</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">influence the odds for participation in physical activities. Special considerations are needed when planning</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">interventions for increased physical activity in children with CP, as the individual prerequisites differ, even among</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">children with the same gross motor function level according to the GMFCS-E&amp;R.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Elsevier Ltd. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22940169 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">42. Epilepsia. 2012 Sep 7. doi: 10.1111/j.1528-1167.2012.03639.x. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Bone mineral density in a population of children and adolescents with cerebral palsy and mental</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">retardation with or without epilepsy</span></strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Coppola G, Fortunato D, Mainolfi C, Porcaro F, Roccaro D, Signoriello G, Operto FF, Verrotti A.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Clinic of Child Neuropsychiatry, University of Salerno, Salerno, Italy Clinic of Child Neuropsychiatry, Second</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">University of Naples, Naples, Italy Department of Radiology, Federico II University, Naples, Italy Department of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Public Health, Second University of Naples, Naples, Italy Department of Pediatrics, University of Chieti, Chieti, Italy.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Purpose: The present study aimed to assess bone mineral density (BMD) in a population of children and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">adolescents with cerebral palsy and mental retardation with or without epilepsy. Methods: One hundred thirteen</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">patients (63 male and 50 female) were recruited for evaluation. Patients were divided in three groups: 40 patients</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(group 1) were affected by cerebral palsy and mental retardation; 47 (group 2) by cerebral palsy, mental</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">retardation, and epilepsy; and 26 (group 3) by epilepsy. The control group consisted of 63 healthy children and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">adolescents. Patients underwent a dual-energy x-ray absorptiometry (DEXA) scan of the lumbar spine (L1-L4), and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">z-score was calculated for each patient; t-score was considered for patients 18 years of age and older. Key</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Findings: Abnormal BMD by DEXA was found in 17 patients (42.5%) in group 1, in 33 (70.2%) in group 2, and in 3</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(11.5%) in group 3. In groups 1 and 2, tetraparesis and severe/profound mental retardation were related to a</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">significantly abnormal BMD (p = 0.003). The multivariate analysis of independent factors on BMD (z-score)</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">revealed a significant correlation between BMD (z-score) and age (p = 0.04), body mass index (BMI; p = 0.002),</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">severe/profound mental retardation (p = 0.03), and epilepsy (p = 0.05). Significance: A significantly lower BMD zscore</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">value was found in patients with cerebral palsy, mental retardation, and epilepsy compared with those without</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">epilepsy. The epileptic disorder appears to be an aggravating factor on bone health when comorbid with cerebral</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">palsy and mental retardation.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">© 2012 International League Against Epilepsy.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22958083 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">43. Fiziol Zh. 2012;58(3):77-84.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Effects of intermittent normobaric hypoxia on the state of the CNS and cerebral circulation in children with</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cerebral palsy.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Yatsenko KV, Berezovskii VA, Deyeva JV.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">We studied the effects of intermittent normobaric hypoxia (INH) on the processes of CNS functions and cerebral</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">circulation recovery in children with cerebral palsy (CP). Altogether, 87 patients (from 8.5 months to 12 years) with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">CP were examined and received the course of treatment. Clinico-neurophysiological examination was performed</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">before the treatment and immediately after termination of the therapeutic course. Patients were divided into two</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">groups; age and sex distributions and clinical manifestations of CP were randomized. The comparison group was</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">formed from 34 children who received the course of the generally accepted complex therapy (medicamental</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">treatment, massage, Bobat-therapy, Vojta-therapy at al). The main group included 53 patients who, in addition to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the same therapy, were exposed to INH using an individual apparatus for artificial mountain air, Borey-M, made in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the Scientific Medico-Engineering Center NORT (Ukrainian National Academy of Sciences, Kyiv). Children of the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">main group were exposed to the dosed normobaric sanogenetic level hypoxia intermittently once per day. For this</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">purpose, we used a normobaric gas hypoxic mixture (12% O2 + 88% N2). Each cycle included a 15-min-long</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">episode of breathing with the gas mixture alternated by a 5-min-long episode of breathing an ambient atmospheric</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">air. The number of hypoxic cycles was gradually increased (from one to three). The entire course of treatment</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">included, on average, 10 sessions. After complex therapy the stable positive effects on the motor status were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">observed in 94% of patients of the main group (exposed to INH) and in 74% of patients of the comparison group</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(unexposed to INH). EEG examination showed that positive dynamics of spectral EEG components were in 70% of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">patients of the main group and in 56% of children of the comparison group. Doppler examination showed that brain</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">hemodynamics was normalized in 85% of patients of the main group and in 59% of children of the comparison</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">group. In the course of ophthalmoscopic examination, we found that the dynamics of indices of the state of the eye</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">fundus were expressed more clearly in children of the main group than in patients of the comparison group (in 32</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and 12% of patients, respectively).</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22946316 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">44. Med Wieku Rozwoj. 2012;16(2):81-88.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Assessment of somatic development and body composition in the 7th year of life in children born as</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">extremely low birth weight infants (=1000g); a multi-centre cross-sectional study of a cohort born between</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">2002 and 2004 in the Malopolska voivodship [Article in Polish]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Kwinta P, Klimek M, Grudzien A, Piatkowska E, Kralisz A, Nitecka M, Profus K, Gasinska M, Pawlik D, Lauterbach</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">R, Olechowski W, Drozdz D, Pietrzyk JJ.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Klinika Chorób Dzieci Katedry Pediatrii, UM UJ, ul. Wielicka 265, 30-663 Kraków, tel./fax (12) 658 44 46,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">kwintap@mp.pl.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Children born with extremely low birth weight often present delayed growth in the first years of their lives: they</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">remain shorter and weigh less than their peers. Current reports published worldwide state that later in life these</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">children are at an increased risk of cardiac and vascular diseases, diabetes and obesity. Abnormal distribution and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the excess of fat tissue predispose them to develop the metabolic syndrome. The aim of the study was to evaluate</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the somatic development of seven-year-old children born with birth-weight =1000 g (ELBW) in the Malopolska</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">voivodship and to estimate the content and distribution of fat tissue. Moreover, the risk factors of disturbed somatic</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">development were evaluated. Materials and methods: Two hundred and four live newborns with birth weight =1000</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">g were born in the Malopolska voivodship between 1.09.2002 and 31.08.2004. One hundred and fifteen of these</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">children (56%) died in early infancy. The study included 81 children in the 7th year of life out of the 89 surviving</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">ones. Their mean gestational age at birth was 27.3 weeks. (SD: 2.1 weeks) and their mean birth-weight was 840 g</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(SD: 130 g). All the children underwent anthropometric measurements and the thickness of the skin fold over the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">triceps was measured. Body mass index (BMI) was calculated and the body composition was assessed by</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">multifrequency bioimpedance. The control group consisted of 39 children born at term chosen randomly from the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">general population and matched with regard to age and sex. Results: The ELBW children in the 7th year of life were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">shorter (z-score: -1.06±1.4 p&lt;0.001), had lower body mass (z-score: -0.57±0.9; p=0.01), smaller head</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">circumference (z-score: -1.2±1.3; p&lt;0.001), lower BMI (z-score: -0.99±1.6; p&lt;0.001) as compared to their peers.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Fat tissue mass was lower in the ELBW group than in the control group (11% vs 16%; p&lt;0.01). The most retarded</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">somatic development was observed in the group of children suffering from cerebral palsy. Conclusions: 1. Children</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">born with ELBW, at 7 years of life, present significantly retarded somatic development as compared with their fullterm</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">peers. 2. The most important risk factor of somatic development disturbances is cerebral palsy. 3. Children</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">born with low birth weight and ELBW, need long term follow up.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22971650 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">45. Int J Integr Care. 2012 Jan;12:e9. Epub 2012 Mar 6.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">A web-based communication system for integrated care in cerebral palsy: experienced contribution to</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">parent-professional communication.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Gulmans J, Vollenbroek-Hutten M, van Gemert-Pijnen L, van Harten W.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Roessingh Research and Development, Institute for Research in Rehabilitation Medicine and Technology,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Enschede, The Netherlands.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">INTRODUCTION: To improve communication in the integrated care setting of children with cerebral palsy, we</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">developed a web-based system for parent-professional and inter-professional communication. The present study</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">aimed to evaluate parents&#8217; experiences regarding the system&#8217;s contribution to their communication with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">professionals during a six-months pilot in three Dutch care regions. In addition, factors associated with parents&#8217;</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">system use and non-use were analyzed. THEORY AND METHODS: The system&#8217;s functional specifications were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">based on key elements of the Chronic Care Model and quality dimensions formulated by the Institute of Medicine.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">At baseline, parents completed a T0-questionnaire on their experiences regarding sufficiency of contact,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">accessibility of professionals, timeliness of information exchange, consistency of information and parents&#8217; role as</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">messenger of information and/or care coordinator. After the pilot, parents completed a T1-questionnaire on their</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">experiences regarding the system&#8217;s contribution to each of these aspects. RESULTS: Of the 30 participating</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">parents 21 had used the system, of which 20 completed the T1-questionnaire. All these parents indicated that they</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">had experienced a contribution of the system to parent-professional communication, especially with respect to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">accessibility of professionals, sufficiency of contact and timeliness of information exchange, and to a lesser extent</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">consistency of information and parents&#8217; messenger/coordinator role. In comparison with non-users, users had less</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">positive baseline experiences with accessibility and a higher number of professionals in the child&#8217;s care network.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">CONCLUSIONS: All users indicated a contribution of the system to parent-professional communication, although</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the extent of the experienced contribution varied considerably. Based on the differences found between users and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">non-users, further research might focus on the system&#8217;s value for complex care networks and problematic access to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">professionals.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22977435 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">46. BMC Res Notes. 2012 Sep 11;5(1):498. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Paediatric palliative home care in areas of Germany with low population density and long distances: a</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">questionnaire survey with general paediatricians.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Kremeike K, Eulitz NK, Jünger S, Sander A, Geraedts M, Reinhardt D.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">BACKGROUND: In 2007, the patient&#8217;s right to specialised palliative home care became law in Germany. However,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">childhood palliative care in territorial states with low patient numbers and long distances requires adapted models to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">ensure an area-wide maintenance. Actually, general paediatricians are the basic care providers for children and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">adolescents. They also provide home care. The aim of this study was to improve the knowledge about general</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">paediatrician&#8217;s involvement in and contribution to palliative care in children. FINDINGS: To evaluate the current</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">status of palliative home care provided by general paediatricians and their cooperation with other paediatric</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">palliative care providers, a questionnaire survey was disseminated to general paediatricians in Lower Saxony, a</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">German federal state with nearly eight million inhabitants and a predominantly rural infrastructure. Data analysis</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">was descriptive. One hundred forty one of 157 included general paediatricians completed the questionnaire</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(response rate: 89.8%). A total of 792 children and adolescents suffering from life-limiting conditions were cared for</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">by these general paediatricians in 2008. Severe cerebral palsy was the most prevalent diagnosis. Eighty-nine per</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cent of the general paediatricians stated that they had professional experience with paediatric palliative care.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Collaboration of general paediatricians and other palliative care providers was stated as not well developed. The</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">support by a specialised team including 24-hour on-call duty and the intensification of educational programs were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">emphasised. CONCLUSIONS: The current regional infrastructure of palliative home care in Lower Saxony can</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">benefit from the establishment of a coordinated network of palliative home care providers.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22967691 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">47. Int J Palliat Nurs. 2012 Jul;18(7):355-9.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Application of the M technique to two severely disabled children in Belarus.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Breen Rickerby K, Cordell B. kbreenrickerby@gmail.com</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Following the early-morning explosion of reactor four at the Chernobyl nuclear plant on 26 April 1986, radioactive</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">fallout fell over 80% of Belarus. More than 2.2 million people were affected, including thousands of children. As a</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">result, there are now over 50,000 children in 600 orphanages in Belarus. Many of the orphanages are without basic</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">amenities and are operating in dire circumstances. This article outlines two case studies of orphaned children with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">profound disabilities in one of these orphanages. The first author, a nurse volunteer from Ireland, used a method of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">touch called the &#8216;M technique&#8217; to calm and soothe the children. The M technique is a gentle repetitive method of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">touch that can be learnt in a few hours. The results suggest that even when the situation appears very challenging,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">simple touch can have a beneficial effect.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22885968 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - indexed for MEDLINE]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">48. J Matern Fetal Neonatal Med. 2012 Oct;25 Suppl 4:21-3.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Chorioamnionitis and prematurity: a critical review.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Martinelli P, Sarno L, Maruotti GM, Paludetto R.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Obstetrics &amp; Gynaecology, High-Risk Pregnancy Unit, University Federico II of Naples, Naples, Italy.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Chorioamnionitis is the inflammatory response to an acute inflammation of the membranes and chorion of the</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">placenta. We provide a critical review of the relationship between chorioamnionitis and the risk of prematurity and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">adverse maternal-fetal outcome. Chorioamnionitis results as a major risk factor for preterm birth and its incidence is</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">strictly related to gestational age. It is associated with a significant maternal, perinatal and long-term adverse</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">outcomes. The principal neonatal complications are neonatal sepsis, pneumonia, bronchopulmonary dysplasia,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">perinatal death, cerebral palsy and intraventricular hemorrhage. The role in neonatal outcome is still controversial</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and more conclusive studies could clarify the relationship between chorioamnionitis and adverse neonatal outcome.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Maternal complications include abnormal progression of labour, caesarean section, postpartum hemorrhage,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">abnormal response after use of oxytocin and placenta abruption. Prompt administration of antibiotics and steroids</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">could improve neonatal outcomes.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22958008 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">49. J Inflamm Res. 2012;5:67-75. Epub 2012 Jul 30.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Placental-mediated increased cytokine response to lipopolysaccharides: a potential mechanism for</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">enhanced inflammation susceptibility of the preterm fetus.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Boles JL, Ross MG, Beloosesky R, Desai M, Belkacemi L.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Obstetrics and Gynecology, Harbor-UCLA Medical Center, Los Angeles Biomedical Research</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Institute at Harbor-UCLA, David Geffen School of Medicine at UCLA, University of California, Los Angeles,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Torrance, CA, USA;</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">BACKGROUND: Cerebral palsy is a nonprogressive motor impairment syndrome that has no effective cure. The</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">etiology of most cases of cerebral palsy remains unknown; however, recent epidemiologic data have demonstrated</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">an association between fetal neurologic injury and infection/inflammation. Maternal infection/inflammation may be</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">associated with the induction of placental cytokines that could result in increased fetal proinflammatory cytokine</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">exposure, and development of neonatal neurologic injury. Therefore, we sought to explore the mechanism by which</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">maternal infection may produce a placental inflammatory response. We specifically examined rat placental cytokine</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">production and activation of the Toll-like receptor 4 (TLR4) pathway in response to lipopolysaccharide exposure at</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">preterm and near-term gestational ages. METHODS: Preterm (e16) or near-term (e20) placental explants from</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">pregnant rats were treated with 0, 1, or 10 μg/mL lipopolysaccharide. Explant integrity was assessed by lactate</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">dehydrogenase assay. Interleukin-6 and tumor necrosis alpha levels were determined using enzyme-linked</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">immunosorbent assay kits. TLR4 and phosphorylated nuclear factor kappa light chain enhancer of activated B cells</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(NF?B) protein expression levels were determined by Western blot analysis. RESULTS: At both e16 and e20,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">lactate dehydrogenase levels were unchanged by treatment with lipopolysaccharide. After exposure to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">lipopolysaccharide, the release of interleukin-6 and tumor necrosis alpha from e16 placental explants increased by</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">4-fold and 8-9-fold, respectively (P &lt; 0.05 versus vehicle). Conversely, interleukin-6 release from e20 explants was</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">not significantly different compared with vehicle, and tumor necrosis alpha release was only 2-fold higher (P &lt; 0.05</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">versus vehicle) following exposure to lipopolysaccharide. Phosphorylated NF?B protein expression was significantly</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">increased in the nuclear fraction from placental explants exposed to lipopolysaccharide at both e16 and e20,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">although TLR4 protein expression was unaffected. CONCLUSION:</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Lipopolysaccharide induces higher interleukin-6 and tumor necrosis alpha expression at e16 versus e20,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">suggesting that preterm placentas may have a greater placental cytokine response to lipopolysaccharide infection.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Furthermore, increased phosphorylated NF?B indicates that placental cytokine induction may occur by activation of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the TLR4 pathway.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 18.0pt; font-family: 'Arial','sans-serif'; color: #008100;">Prevention and Cure</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22924006 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process] PMCID: PMC3422858</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">50. Epilepsy Res Treat. 2012;2012:747565. Epub 2012 Jul 12.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Epileptic encephalopathy in children with risk factors for brain damage.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Ricardo-Garcell J, Harmony T, Porras-Kattz E, Colmenero-Batallán MJ, Barrera-Reséndiz JE, Fernández-Bouzas</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">A, Cruz-Rivero E.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Unidad de Investigación en Neurodesarrollo, Departamento de Neurobiología Conductual y Cognitiva, Instituto de</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla, 76230 Querétaro, ORO, Mexico.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">In the study of 887 new born infants with prenatal and perinatal risk factors for brain damage, 11 children with West</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">syndrome that progressed into Lennox-Gastaut syndrome and another 4 children with Lennox-Gastaut syndrome</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">that had not been preceded by West syndrome were found. In this study we present the main findings of these 15</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">subjects. In all infants multifactor antecedents were detected. The most frequent risk factors were prematurity and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">severe asphyxia; however placenta disorders, sepsis, and hyperbilirubinemia were also frequent. In all infants MRI</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">direct or secondary features of periventricular leukomalacia were observed. Followup of all infants showed</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">moderate to severe neurodevelopmental delay as well as cerebral palsy. It is concluded that prenatal and perinatal</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">risk factors for brain damage are very important antecedents that should be taken into account to follow up those</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">infants from an early age in order to detect and treat as early as possible an epileptic encephalopathy.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22957240 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed] PMCID: PMC3420497</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">51. Congenit Anom (Kyoto). 2012 Sep;52(3):147-54. doi: 10.1111/j.1741-4520.2012.00375.x.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Pluripotent stem cells are protected from cytomegalovirus infection at multiple points: Implications of a</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">new pathogenesis for congenital anomaly caused by cytomegalovirus.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Kawasaki H.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Regenerative &amp; Infectious Pathology, Hamamatsu University School of Medicine, Hamamatsu,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Japan.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">In humans, the cytomegalovirus (CMV) is the most significant cause of intrauterine infections that cause congenital</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">anomalies. Intrauterine infection with human CMV is thought to be responsible for a variety of abnormalities,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">including mental retardation, microcephaly, developmental delay, seizure disorders, and cerebral palsy, depending</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">on the timing of the fetal infection, the infectious route, and the virulence of the virus. In addition to the adaptive</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">immune system, the embryo has potential resistance to CMV during early embryogenesis. Embryonic stem (ES)</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cells are more resistant to CMV than most other cell types, although the mechanism responsible for this resistance</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">is not well understood. ES cells allow approximately 20-fold less murine CMV (MCMV) DNA to enter the nucleus</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">than mouse embryonic fibroblasts (MEFs), and this inhibition occurs in a multistep manner. In situ hybridization</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">showed that ES cell nuclei had significantly less MCMV DNA than MEF nuclei. This finding appears to be supported</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">by the fact that ES cells express less heparan sulfate, ß1-integrin, and vimentin and have fewer nuclear pores than</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">differentiated cells such as MEF. This may reduce the ability of MCMV to attach to and enter the cellular</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">membrane, translocate to the nucleus, and cross the nuclear membrane in pluripotent stem cells (ES-induced</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">pluripotent stem cells). This finding may indicate a new pathogenesis for the congenital anomaly caused by CMV.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">© 2012 The Author. Congenital Anomalies © 2012 Japanese Teratology Society.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22925215 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">52. Neuropediatrics. 2012 Aug 29. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Head Circumference Growth Function as a Marker of Neurological Impairment in a Cohort of Microcephalic</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Infants and Children.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Coronado R, Giraldo J, Macaya A, Roig M.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Secció de Neurologia Infantil, Hospital Vall d&#8217;Hebron, Universitat Autònoma de Barcelona and Unitat de Neurologia</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Pediàtrica, Consorci Sanitari de Terrassa, Spain.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Our aim was to investigate the correlations between head circumference (HC) growth and neurological impairment</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">in microcephalic patients.HC charts of 3,269 patients from a tertiary pediatric neurology section were reviewed and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">136 microcephalic participants were selected. Standardized HC Minimum, HC Drop, and HC Catch-up variables</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">were defined. Children with evidence of significant learning disability and/or significant cerebral palsy were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">classified within the neurologically impaired group and the rest of participants within the normal group.Using</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">discriminant analysis, we found that HC Minimum and HC Drop were relevant markers of neurological impairment.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">A positive HC Catch-up was significantly linked to a better outcome although this variable did not add significant</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">information to HC Minimum and HC Drop. A Fisher linear discrimination cutoff function (C-function) was obtained as</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">C = HC Minimum + HC Drop with a cutoff level of C = -4.28 standard deviations (SD).In our cohort, the addition of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the lowest HC z-score to the preceding HC z-score drop was below -4.28 SD in 6 out of 10 neurologically impaired</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">patients , whereas in the normal group, the result was over -4.28 SD in 9 out of 10 participants.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22932949 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">53. Pediatrics. 2012 Sep;130(3):390-6. Epub 2012 Aug 29.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Neurologic disorders among pediatric deaths associated with the 2009 pandemic influenza.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Blanton L, Peacock G, Cox C, Jhung M, Finelli L, Moore C.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Mailstop A-32, Atlanta, GA 30333.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">lblanton@cdc.gov.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">OBJECTIVE: The goal of this study was to describe reported influenza A (H1N1)pdm09 virus (pH1N1)-associated</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">deaths in children with underlying neurologic disorders. METHODS: The study compared demographic</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">characteristics, clinical course, and location of death of pH1N1-associated deaths among children with and without</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">underlying neurologic disorders reported to the Centers for Disease Control and Prevention. RESULTS: Of 336</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">pH1N1-associated pediatric deaths with information on underlying conditions, 227 (68%) children had at least 1</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">underlying condition that conferred an increased risk of complications of influenza. Neurologic disorders were most</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">frequently reported (146 of 227 [64%]), and, of those disorders, neurodevelopmental disorders such as cerebral</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">palsy and intellectual disability were most common. Children with neurologic disorders were older (P = .02), had a</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">significantly longer duration of illness from onset to death (P &lt; .01), and were more likely to die in the hospital</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">versus at home or in the emergency department (P &lt; .01) compared with children without underlying medical</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">conditions. Many children with neurologic disorders had additional risk factors for influenza-related complications,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">especially pulmonary disorders (48%). Children without underlying conditions were significantly more likely to have</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">a positive result from a sterile-site bacterial culture than were those with an underlying neurologic disorder (P &lt; .01).</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">CONCLUSIONS: Neurologic disorders were reported in nearly two-thirds of pH1N1-associated pediatric deaths</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">with an underlying medical condition. Because of the potential for severe outcomes, children with underlying</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">neurologic disorders should receive influenza vaccine and be treated early and aggressively if they develop</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">influenza-like illness.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22931899 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">54. Eur J Obstet Gynecol Reprod Biol. 2012 Sep 1. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Independent effects of pregnancy induced hypertension on childhood development: a retrospective cohort</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">study.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Love ER, Crum J, Bhattacharya S.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">University of Aberdeen, United Kingdom.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">OBJECTIVE: To assess whether maternal hypertension in pregnancy was independently associated with additional</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">support needs in children. STUDY DESIGN: Retrospective cohort study using linkage of birth records of all</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">singleton deliveries occurring in primigravidae between 1995 and 2008 in Aberdeen Maternity and Neonatal</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Databank with the Support Needs System (SNS) dataset in Grampian. Crude and adjusted odds ratios with 95%</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">confidence intervals of having a record in SNS in the presence of maternal pregnancy induced hypertension were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">calculated using logistic regression taking account of confounders such as preterm birth and low birth weight.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">RESULTS: After adjusting for confounding factors, neither pre-eclampsia {Adj OR 0.80 (95% CI 0.60, 1.07)} nor</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">gestational hypertension {Adj OR 1.16 (95% CI 0.99, 1.36)} showed statistically significant associations with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">additional support needs. An association of pre-eclampsia with cerebral palsy seen on univariate analysis also</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">disappeared on adjusting for confounders {Adj OR 1.26 (95% CI 0.43, 3.68)}. Birth before 32 weeks gestation and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">birthweight below 1500g were independently associated with additional support needs in children. CONCLUSIONS:</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">While maternal hypertension was not found to be independently associated with special needs in children, very</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">preterm birth and very low birthweight showed an association.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22948131 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">55. Acta Med Iran. 2012 Jul;50(7):473-6.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Intraventricular hemorrhage in premature infants and its association with pneumothorax.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Pishva N, Parsa G, Saki F, Saki M, Saki MR.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Neonatology Research Center, Namazi Hospital, Shiraz University of Medical Science, Shiraz, Iran.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Intraventricular hemorrhage (IVH) is one of the major causes of the cerebral palsy and mental retardation.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Prevention and early management of these neurologic developmental problems will require determining the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">perinatal risk factors associated with this clinical entity. Pneumothorax increase the risk of IVH, and cause of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">pneumothorax has an important effect in severity of IVH. This is a prospective cross sectional study in 2010. This</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">study includes 150 preterm neonates. Cranial ultrasound was performed in all neonates in age 3, 7, 30, 60, just</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">after pneumothorax and every 2 week until chest tube discontinuation. Then prevalence of IVH and pneumothorax</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">was calculated in preterm infant and severity of IVH was investigated before and after development of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">pneumothorax, and this comparison was divided by different causes of pneumothorax with SPSS version 11.5.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Prevalence of IVH and pneumothorax in preterm infants were 30% and 10% respectively. Pneumothorax was not a</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">risk factor of IVH (P&gt;0.05), but prevalence of pneumothorax caused by RDS was a risk factor of development of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">IVH (P=0.01). Also pneumothorax in patients with birth weight less than 1000 g and gestational age less than 28</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">week was a risk factor of IVH pneumothorax (P=0.008, P=0.01 respectively). Our study discusses the differences in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">previous studies about association of pneumothorax and IVH. Also we suggest the hypothesis that lack of cerebral</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">autoregulation in neonates with gestational age less than 28 week can cause IVH development after hypotension</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">induces by pneumothorax.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22930379 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">56. Pediatrics. 2012 Sep 3. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">EEG for Predicting Early Neurodevelopment in Preterm Infants: An Observational Cohort Study.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Hayashi-Kurahashi N, Kidokoro H, Kubota T, Maruyama K, Kato Y, Kato T, Natsume J, Hayakawa F, Watanabe K,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Okumura A.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Pediatric Neurology, Central Hospital of Aichi Welfare Center for Persons with Developmental</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Disabilities, Kasugai, Japan;</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">OBJECTIVE: To clarify the prognostic value of conventional EEG for the identification of preterm infants at risk for</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">subsequent adverse neurodevelopment in the current perinatal care and medicine setting. METHODS: We studied</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">780 EEG records of 333 preterm infants born &lt;34 weeks&#8217; gestation between 2002 and 2008. Serial EEG recordings</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">were conducted during 3 time periods; at least once each within days 6 (first period), during days 7 to 19 (second</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">period), and days 20 to 36 (third period). The presence and the grade of EEG background abnormalities were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">assessed according to an established classification system. Neurodevelopmental outcomes were assessed at a</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">corrected age of 12 to 18 months. RESULTS: Of the 333 infants, 33 (10%) had developmental delay and 34 (10%)</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">had cerebral palsy. The presence of EEG abnormalities was significantly predictive of developmental delay and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cerebral palsy at all 3 time periods: the first period (n = 265; odds ratio [OR], 4.5; 95% confidence interval [CI], 2.2-</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">9.4), the second period (n = 278; OR, 7.6; 95% CI, 3.6-16), and the third period (n = 237; OR, 5.9; 95% CI, 2.8-13).</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The grade of EEG abnormalities correlated with the incidence of developmental delay or cerebral palsy in all</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">periods (P &lt; .001). After controlling for other clinical variables, including severe brain injury, EEG abnormality in the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">second period was an independent predictor of developmental delay (OR, 3.2; 95% CI, 1.1-9.7) and cerebral palsy</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(OR, 6.8; 95% CI 2.0-23). CONCLUSIONS: EEG abnormalities within the first month of life significantly predict</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">adverse neurodevelopment at a corrected age of 12 to 18 months in the current preterm survivor.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22945413 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">57. Pediatrics. 2012 Sep 10. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Incidence of Chronic Bilirubin Encephalopathy in Canada, 2007-2008.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Sgro M, Campbell DM, Kandasamy S, Shah V.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Keenan Research Centre, Li Ka Shing Knowledge Institute, and.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">BACKGROUND AND OBJECTIVES: Despite the implementation of screening guidelines to identify infants at risk</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">for hyperbilirubinemia, chronic bilirubin encephalopathy (CBE) continues to be reported worldwide in otherwise</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">healthy infants. The incidence of CBE in Canada is unknown. The objectives of this study were to establish the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">incidence of CBE in Canada and identify epidemiological and medical risk factors associated with its occurrence.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">METHODS: Data on infants were collected prospectively through the Canadian Pediatric Surveillance Program.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Infants born between January 1, 2007 and December 31, 2008 were included if they either had symptoms of CBE</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and a history of hyperbilirubinemia, or if they presented in the newborn period with severe hyperbilirubinemia and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">an abnormal MRI finding as per the reporting physician. RESULTS: During the study period, 20 cases were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">identified; follow-up data were available for 14 of these. The causes for the hyperbilirubinemia included glucose-6-</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">phosphate dehydrogenase deficiency (n = 5), sepsis (n = 2), ABO incompatibility and other red blood cell antibodies</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">(n = 7). Fifteen infants had abnormal brain MRI findings during the neonatal period. At follow-up, 5 infants</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">developed classic choreoathetoid cerebral palsy, 6 had spectrum of neurologic dysfunction and developmental</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">delay (as described by the reporting physician), and 3 were healthy. CONCLUSIONS: CBE continues to occur in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Canada at an incidence that appears to be higher than previously reported.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22966025 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">58. J Pediatr. 2012 Aug 31. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Normal Imaging in Patients with Cerebral Palsy: What Does It Tell Us?</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Benini R, Dagenais L, Shevell MI; Registre de la Paralysie Cérébrale au Québec (Quebec Cerebral Palsy Registry)</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Consortium.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Division of Pediatric Neurology, McGill University, Montreal, Canada and Montreal Children&#8217;s Hospital-McGill</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">University Health Center, Montreal, Quebec, Canada.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">OBJECTIVE: To identify distinctive clinical features characterizing children with cerebral palsy (CP) and normalappearing</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">magnetic resonance imaging (MRI) findings. STUDY DESIGN: Using a population-based CP registry, the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Registre de la Paralysie Cérébrale au Québec (Quebec Cerebral Palsy Registry), various antenatal, perinatal, and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">postnatal predictor variables, as well as current phenotype, were compared in patients with normal-appearing MRI</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">findings and those with abnormal MRI findings. RESULTS: Of the 213 patients evaluated, 126 (60%) had MRI</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">imaging results available and were included in our analysis. Of these 126 patients, 90 (71%; 51 males, 39 females)</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">had abnormal findings and 36 (29%; 17 males and 19 females) had normal-appearing findings. Compared with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">other CP variants, normal-appearing MRI was more prevalent (P = .001) in dyskinetic CP (72.7%; 8 of 11) and less</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">prevalent (P = .002) in spastic hemiplegic CP (10%; 4 of 40). There were no significant differences between the 2</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">groups (P &gt; .05) in terms of the prevalence of perinatal or postnatal clinical features or clinical outcomes.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Furthermore, 42% (15 of 36) of the children with normal-appearing MRI exhibited a high degree of functional</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">disability (Gross Motor Functional Classification System IV-V), compared with 33% (30 of 90) with abnormal MRI.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">CONCLUSION: No clinical features, except a higher prevalence of dyskinetic CP, was identified in the children with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">normal-appearing MRI. More refined imaging techniques may be needed to evaluate patients with normalappearing</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">MRI findings. Furthermore, genetic or functional, rather than gross structural lesions, may underlie the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">pathophysiology of CP in this cohort. Finally, the high proportion of substantial functional disability underscores the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">importance of continuous follow-up even in the absence of early structural abnormalities on imaging.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Mosby, Inc. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22944004 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">59. AJNR Am J Neuroradiol. 2012 Sep 13. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Diffusion Tensor Imaging-Demonstrated Differences between Hemiplegic and Diplegic Cerebral Palsy with</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Symmetric Periventricular Leukomalacia.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Cho HK, Jang SH, Lee E, Kim SY, Kim S, Kwon YH, Son SM.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Departments of Physical Medicine and Rehabilitation, Pediatrics, and Physical Therapy, College of Science and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Technology, College of Medicine, Yeungnam University, Taegu, Republic of Korea; and Department of Pediatrics,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">College of Medicine, Eulji University, Daejeon, Republic of Korea.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">BACKGROUND AND PURPOSE: Patients with cerebral palsy have variable clinical presentations such as</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">hemiplegic, diplegic, or quadriplegic patterns though they have PVL on conventional MR images. The authors</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">investigated whether DTT can differentiate between hemiplegic and diplegic CP in patients presenting with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">symmetric PVL on conventional MR images. MATERIALS AND METHODS: One hundred thirteen consecutive</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">pediatric patients with definite hemiplegic (59 patients; 30 boys, 29 girls; mean age, 34.19 months; range, 24-52</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">months) or diplegic (54 patients; 27 boys, 27 girls; mean age, 31.07 months; range, 24-48 months) symptoms and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">bilateral symmetric PVL on conventional brain MR imaging were recruited. The states of CSTs were examined by</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">using DTT, and the asymmetries of right and left CSTs in the hemiplegic and diplegic groups were compared by</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">using asymmetric anisotropy indexes and asymmetric mean diffusivity indexes. RESULTS: All patients in the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">hemiplegic group with asymmetric results exhibited disrupted integrities of more affected CSTs and sparing of less</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">affected CSTs. However, diplegic patients revealed symmetric disrupted findings of the right and left CSTs at the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">upper periventricular level. Asymmetric anisotropy index and asymmetric mean diffusivity index values were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">significantly higher in the hemiplegic group than in the diplegic group (P &lt; .05), and these results of DTT</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">significantly corresponded with their typical clinical manifestation. CONCLUSIONS: DTT may be very useful for the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">detailed estimation of the CST state in patients with bilateral symmetric PVL.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22976239 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">60. Am J Obstet Gynecol. 2012 Sep;207(3):192.e1-9. Epub 2012 Jul 7.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Brain damage in preterm newborns and maternal medication: the ELGAN Study.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Tyler CP, Paneth N, Allred EN, Hirtz D, Kuban K, McElrath T, O&#8217;Shea TM, Miller C, Leviton A; ELGAN Study</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Investigators.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Epidemiology, College of Human Medicine, Michigan State University, East Lansing, MI.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">OBJECTIVE: We sought to evaluate the association between maternal medication use during pregnancy and</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cerebral white matter damage and cerebral palsy (CP) among very preterm infants. STUDY DESIGN: This analysis</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of data from the Extremely Low Gestational Age Newborns (ELGAN) Study included 877 infants born &lt;28 weeks&#8217;</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">gestation. Mothers were interviewed, charts were reviewed, placentas were cultured and assessed histologically,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and children were evaluated at 24 months corrected age. A diagnostic algorithm classified neurologic findings as</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">quadriparetic CP, diparetic CP, hemiparetic CP, or no CP. RESULTS: After adjustment for the potential</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">confounding of disorders for which medications might have been indicated, the risk of quadriparetic CP remained</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">elevated among the infants of mothers who consumed aspirin (odds ratio [OR], 3.0; 95% confidence interval [CI],</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">1.3-6.9) and nonsteroidal antiinflammatory drugs (NSAIDs) (OR, 2.4; 95% CI, 1.04-5.8). The risk of diparetic CP</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">was also associated with maternal consumption of an NSAID, but only if the consumption was not approved by a</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">physician (OR, 3.5; 95% CI 1.1-11.0). CONCLUSION:</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The possibility that aspirin and NSAID use in pregnancy could lead to perinatal brain damage cannot be excluded.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 Mosby, Inc. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22939723 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process] PMCID: PMC3432943 [Available on 2013/9/1]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">61. J Physiol. 2012 Sep 10. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Reduced Corticomotor Excitability and Motor Skills Development in Children Borm Preterm.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Pitcher JB, Schneider LA, Burns NR, Drysdale JL, Higgins RD, Ridding MC, Nettelbeck TJ, Haslam RR, Robinson</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">JS.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">University of Adelaide</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The mechanisms underlying the altered neurodevelopment commonly experienced by children born preterm, but</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">without brain lesions, remain unknown. While individuals born the earliest are at most risk, late preterm children</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">also experience significant motor, cognitive and behavioural dysfunction from school age, and reduced income and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">educational attainment in adulthood. We used transcranial magnetic stimulation and functional assessments to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">examine corticomotor development in 151 non-cerebral palsy children aged 10-13 years and born after gestations</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of 25 &#8211; 41 completed weeks. We hypothesised that motor cortex and corticospinal development are altered in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">preterm children and underpins at least some of their motor dysfunction. We report for the first time that every week</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of reduced gestation is associated with a reduction in corticomotor excitability that remains evident in late</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">childhood. This reduced excitability was associated with poorer motor skill development, particularly manual</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">dexterity. However, child adiposity, sex and socio-economic factors regarding the child&#8217;s home environment soon</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">after birth were also powerful influences on motor skills development. Preterm birth was also associated with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">reduced left hemisphere lateralisation, but without increasing the likelihood of being left-handed per se. These</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">corticomotor findings have implications for normal motor development, but also raise questions regarding possible</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">longer-term consequences of preterm birth on motor function.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22966161 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">62. Bone Marrow Transplant. 2012 Sep 10. doi: 10.1038/bmt.2012.169. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Rescuing the neonatal brain from hypoxic injury with autologous cord blood.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Liao Y, Cotten M, Tan S, Kurtzberg J, Cairo MS.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Pediatrics, New York Medical College, Valhalla, NY, USA.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Brain injury resulting from perinatal hypoxic-ischemic encephalopathy (HIE) is a major cause of acute mortality in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">infants and chronic neurologic disability in surviving children. Recent multicenter clinical trials demonstrated the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">effectiveness of hypothermia initiated within the first 6 postnatal hours to reduce the risk of death or major</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">neurological disabilities among neonates with HIE. However, in these trials, approximately 40% of cooled infants</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">died or survived with significant impairments. Therefore, adjunct therapies are required to improve the outcome in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">neonates with HIE. Cord blood (CB) is a rich source of stem cells. Administration of human CB cells in animal</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">models of HIE has generally resulted in improved outcomes and multiple mechanisms have been suggested</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">including anti-inflammation, release of neurotrophic factors and stimulation of endogenous neurogenesis.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Investigators at Duke are conducting studies of autologous CB infusion in neonates with HIE and in children with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cerebral palsy. These pilot studies indicate no added risk from the regimens used, but results of ongoing placebocontrolled</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">trials are needed to assess efficacy. Meanwhile, further investigations are warranted to determine the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">best strategies, that is, timing, dosing, route of delivery, choice of stem cells and ex vivo modulations, to attain longterm</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">benefits of CB stem cell therapy.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22964590 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">63. Brain. 2012 Sep 10. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">van Gassen KL, van der Heijden CD, de Bot ST, den Dunnen WF, van den Berg LH, Verschuuren-Bemelmans CC,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Kremer HP, Veldink JH, Kamsteeg EJ, Scheffer H, van de Warrenburg BP.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Department of Human Genetics, Institute for Genetic and Metabolic Disease, Radboud University Nijmegen</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Medical Centre, Nijmegen, 6500 HB, The Netherlands.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Spastic paraplegia type 7 is an autosomal recessive neurodegenerative disorder mainly characterized by</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">progressive bilateral lower limb spasticity and referred to as a form of hereditary spastic paraplegia. Additional</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">disease features may also be observed as part of a more complex phenotype. Many different mutations have</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">already been identified, but no genotype-phenotype correlations have been found so far. From a total of almost 800</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">patients referred for testing, we identified 60 patients with mutations in the SPG7 gene. We identified 14 previously</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">unreported mutations and detected a high recurrence rate of several earlier reported mutations. We were able to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">collect detailed clinical data for 49 patients, who were ranked based on a pure versus complex phenotype, ataxia</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">versus no ataxia and missense versus null mutations. A generally complex phenotype occurred in 69% of all</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">patients and was associated with a younger age at onset (trend with P = 0.07). Ataxia was observed in 57% of all</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">patients. We found that null mutations were associated with the co-occurrence of cerebellar ataxia (trend with P =</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">0.06). The c.1409 G &gt; A (p.Arg470Gln) mutation, which was found homozygously in two sibs, was associated with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">a specific complex phenotype that included predominant visual loss due to optical nerve atrophy. Neuropathology in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">one of these cases showed severe degeneration of the optic system, with less severe degeneration of the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">ascending tracts of the spinal cord and cerebellum. Other disease features encountered in this cohort included</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cervical dystonia, vertical gaze palsy, ptosis and severe intellectual disability. In this large Dutch cohort, we seem to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">have identified the first genotype-phenotype correlation in spastic paraplegia type 7 by observing an association</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">between the cerebellar phenotype of spastic paraplegia type 7 and SPG7 null alleles. An overlapping phenotypic</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">presentation with its biological counterpart AFG3L2, which when mutated causes spinocerebellar ataxia type 28, is</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">apparent and possibly suggests that abnormal levels of the SPG7 protein impact the function of the mitochondrial</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">ATPases associated with diverse cellular activities-protease complex (formed by SPG7 and AFG3L2) in the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cerebellum. In addition, a missense mutation in exon 10 resulted in predominant optical nerve atrophy, which might</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">suggest deleterious interactions of this SPG7 variant with its substrate OPA1, the mutated gene product in optic</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">atrophy type 1. Functional studies are required to further investigate these interactions.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22964162 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">64. Gynecol Obstet Fertil. 2012 Sep 17. pii: S1297-9589(12)00232-9. doi: 10.1016/j.gyobfe.2012.08.005. [Epub</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Use of magnesium sulfate in obstetrics [Article in French]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Kayem G, Mandelbrot L, Haddad B.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Service de gynécologie-obstétrique, hôpital Louis-Mourier, AP-HP, HUPNVS, université Paris Diderot, 178, rue des</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Renouillers, 92700 Colombes, France. Electronic address: gkayem@gmail.com.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Magnesium sulfate (MgSO(4)) is the best treatment of eclampsia, reduces the risk of recurrence better than other</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">anticonvulsants and is recommended as first line in cases of eclampsia. In cases of severe pre-eclampsia and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">especially when prodromes are present, MgSO(4) reduces better than conventional anticonvulsants the risk of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">eclampsia. More recently, MgSO(4) was used in cases of preterm delivery to reduce the risk of cerebral palsy in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">premature infants. Three large randomized trials have obtained convergent results which all tended to show a</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">neuroprotective effect of MgSO(4). These trials were included in three meta-analyzes that showed a 30% reduction</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">in the incidence of cerebral palsy before 32weeks gestation suggesting that this drug should be used in cases of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">preterm birth. A protocol using low doses associated with a well-conducted maternal surveillance reduces of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">maternal hypermagnesemia and the risk of maternal toxicity.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012. Published by Elsevier SAS.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22995056 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">65. Z Geburtshilfe Neonatol. 2012 Aug;216(4):173-6. Epub 2012 Aug 27.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Intrauterine inflammation and its sequelae: does chorioamnionitis really matter for outcome of very low</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">birth weight infants? [Article in German]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Thomas W, Speer CP.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Universitäts-Kinderklinik, Würzburg.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Infections in utero and chorioamnionitis are major risk factors for spontaneous, very early premature birth. Thus</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">chorioamnionitis contributes significantly to prematurity-associated morbidity and mortality. Evidence for a gestation</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">-independent effect of chorioamnionitis on the outcome of very low birth weight infants is much more difficult to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">obtain as most of the studies addressing this issue lack a normal &#8220;control group&#8221;, as prematurity is mostly</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">associated with some kind of prenatal pathology with a potential influence on neonatal outcome. Moreover, major</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">advances in perinatal and neonatal care for this high-risk group have mitigated the impact of chorioamnionitis on</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">morbidity and mortality of very low birth weight infants. Histological chorioamnionitis is associated with a lower</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">incidence and severity of respiratory distress syndrome. However, short-term maturational effects on the lung are</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">associated with a higher susceptibility for postnatal noxious events, such as mechanical ventilation, thus</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">contributing to the risk of bronchopulmonary dysplasia. Data regarding the importance of chorioamnionitis for brain</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">damage of the very premature infant are inconsistent although meta-analyses have shown an increased risk of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">cystic periventricular leukomalacia and cerebral palsy after exposure to inflammation in utero. Very recent</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">epidemiological studies suggest a role of chorioamnionitis in the aetiology and pathogenesis of retinopathy of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">prematurity.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">© Georg Thieme Verlag KG Stuttgart · New York.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22926817 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">66. Arch Med Res. 2012 Sep 6. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Hearing Loss, Auditory Neuropathy, and Neurological Comorbidity in Children with Birthweight &lt;750 g.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Martínez-Cruz CF, Alonso-Themann PG, Poblano A, Ochoa-López JM.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Instituto Nacional de Perinatología Dr. Isidro Espinosa de los Reyes (INPer), Mexico, D.F., Mexico.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">BACKGROUND AND AIMS: The current literature considers a birthweight &lt;1,500 g as a risk factor for</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">sensorineural hearing loss (SNHL, hearing threshold &gt;25 decibels), auditory neuropathy (AN), and several</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">neurological sequelae. The aim of the study was to determine the frequency and risk factors associated with SNHL,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">AN, and neurological morbidity in a group of children with birthweights of &lt;750 g treated at a neonatal care unit and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">recruited into a long-term follow-up study. METHODS: A case-control study was carried out. Inclusion criteria were</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">birthweight &lt;750 g and born between the years 2000 and 2010. We performed brainstem auditory-evoked</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">potentials (BAEP), evoked otoacoustic emissions (EOAE) and free-field audiometry (FFA) in this population.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">eonatal variables and procedures were compared between children with SNHL and children with normal bilateral</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">hearing (NBH). RESULTS: A total of 93 children with a mean age of 4 years were included in the follow-up. Six</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">children (6.4%) had SNHL and 87 had NBH. We were unable to identify AN in the sample. Mean weight for this</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">sample was 673 ± 68 g and gestational age 27.5 ± 2 weeks. Variables reflecting differences between groups</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">included days under mechanical ventilation, furosemide treatment, and bronchopulmonary dysplasia. In the SNHL</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">group, three patients had periventricular leukomalacia, two had hydrocephalus, and one patient had cerebral palsy.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">CONCLUSIONS: Frequency of SNHL in children with birthweights &lt;750 g was higher than in other premature</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">infants and was related with mechanical ventilation, furosemide application, and bronchopulmonary dysplasia.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Association with other neurological morbidities was frequent. Early diagnosis and intervention are required.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Copyright © 2012 IMSS. Published by Elsevier Inc. All rights reserved.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22960856 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">67. J Matern Fetal Neonatal Med. 2012 Oct;25 Suppl 4:86-8.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Therapeutic hypothermia in the prevention of hypoxic-ischaemic encephalopathy: new categories to be</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">enrolled.</span></strong></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Gancia P, Pomero G.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Neonatal Intensive Care &#8211; Neonatology , ASO S. Croce e Carle, Cuneo , Italy.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Therapeutic hypothermia is now the standard of care for brain injury control in term infants with perinatal hypoxic</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">ischemic encephalopathy (HIE). Accumulated evidence shows a reduction in mortality and long-term</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">neurodevelopmental disability at 12-24 months of age, with more favourable effects in the less severe forms of HIE.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Only few trials recruited newborns &lt;36 weeks gestational age, or mild-to-moderate encephalopathy with base</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">deficit (BD) &lt;16. The new categories of patients to be enrolled should include (late) preterm infants, neonates with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">unexpected postnatal collapse, and newborns with stroke. Preterm HIE: Therapeutic hypothermia shows a good</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">safety profile in clinical studies, and no adverse effects were noted in the preterm fetal animal model. Recently, it</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">has been shown that mild hypothermia in preterm newborns with necrotizing enterocolitis (NEC) and multiple organ</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">dysfunction syndrome (MODS) does not increase mortality, bleeding, infection, or need for inotropes in cooled</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">newborns. A pilot study (NCT00620711) is currently recruiting newborns of &gt; 32 but &lt; 36 weeks gestation with</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">standard criteria for HIE. Postnatal Collapse: The postnatal collapse (PNC) is a rare (0.03-0.5/1000 live births) but</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">life-threatening hypoxic-ischemic event. No clinical trials of therapeutic hypothermia have specifically addressed to</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">PNC. Nevertheless, a beneficial effect of brain cooling is expectable, and it has been proposed to include in brain</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">hypothermia trials the infants with PNC fulfilling the entry criteria for HIE. Stroke: Perinatal arterial ischemic stroke is</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the most common cause of cerebral palsy (CP) in term and near-term newborn. In a systematic review and metaanalysis</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of animal studies of focal cerebral ischemia, hypothermia reduced the infarct size by 44%. No specific</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">neuroprotective interventions are available for the management of acute perinatal stroke. Hypothermia may</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">decrease seizures in newborns with encephalopathy and a focal infarct, potentially improving the long-term</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">outcome for these infants. Concluding remarks: Future studies of therapeutic hypothermia should include the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">categories of newborns excluded from the published clinical trials, that is infants &lt;36 weeks gestation, PNC or</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">stroke, or admitted outside of the established 6-hour window, and with encephalopathy not imputable to HIE. New</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">entry criteria will allow significant number of newborns to benefit from the treatment.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22958032 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">Cerebral Palsy Alliance</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 8.0pt; font-family: 'Arial','sans-serif'; color: #4d4d4d;">PO Box 184 Brookvale NSW 2100 Australia | T +61 2 9479 7200 | www.cerebralpalsy.org.au</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">68. J Community Health. 2012 Aug 29. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Cerebral Palsy Among Children Seen in the Neurology Clinic of Federal Medical Centre (FMC), Asaba.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Okike CO, Onyire BN, Ezeonu CT, Agumadu HU, Adeniran KA, Manyike PC.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Federal Medical Centre, Asaba, Nigeria, cliffordokike@yahoo.com.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Cerebral palsy (CP) is a non-progressive disorder of motor function caused by irreversible damage to the immature</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">brain. The disorder may be associated with seizure, mental retardation, visual and hearing defects. This study was</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">designed to determine the types of CP, the risk factors and the co-morbidities associated with the disorder. Records</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">of patients who were seen in the neurology clinic were kept for two years (June 2009-July 2011). Medical history</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">and examination were essentially used to determine risk factors, antenatal care and co-morbidities. Data was</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">analyzed using SPSS soft-ware. CP made up 45 % of 60 neurological cases and 0.006 % of 4,873 patients seen in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the clinic with a male to female ratio of 1.1:1. Birth asphyxia was the commonest risk factor for the development of</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">the disorder while seizure disorder among others was the commonest co-morbid state.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22926682 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">69. Semin Reprod Med. 2012 Apr;30(2):84-91. Epub 2012 Apr 27.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Adverse perinatal events associated with ART.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Skora D, Frankfurter D.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The George Washington University, Medical Faculty Associates, Washington, DC 20037, USA.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Since the advent of ART, much research has focused on the potential adverse for resultant harm. Prematurity, low</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">birth-weight, PIH, congenital malformations, and CP are closely tied to multiple gestation. With the increase in</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">elective single embryo transfer, there will be a reduction in adversity related to multiple birth. It is understood that</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">underlying causes of infertility, including advanced maternal age, PCOS, thyroid disease, and uterine fibroids,</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">predispose to adverse outcomes. However, imprinting abnormalities do not appear to stem from multiple births, and</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">thus the need to consider the association between fertility treatment and methylation disorders remains essential.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">These, as well as risks of multi-fetal gestation, must be discussed with patients when considering using assisted</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">reproduction.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22549708 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - indexed for MEDLINE]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">70. J Genet Couns. 2012 Sep 8. [Epub ahead of print]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">On the Precarious Cusp of Genetic Medicine.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Powell AM.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Center for Prevention &amp; Early Intervention Policy, Florida State University, Tallahassee, FL, USA,</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">apowell@mindspring.com.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">This is the story of two brothers at the dawn of genetic medicine, the first severely disabled by cerebral palsy, the</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">other an MD scientist who happens to uncover the genetic cause of his brother&#8217;s condition. A test confirms their</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">mother&#8217;s carrier status. But what about their only sister-is she a carrier as well? The question would send the author</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">down a path she never dreamed she would take.</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22961238 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - as supplied by publisher]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: white;">Cerebral Palsy Research News ~ September 2012</span></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">71. No To Hattatsu. 2012 May;44(3):221-4.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">The present status and problems of compensation system for birth troubles [Article in Japanese]</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Sugai K, Aso K.</span></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">sugaik@ncnp.go.jp</span></p>
<p style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22712223 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - indexed for MEDLINE]</span></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">72. Nurs Law Regan Rep. 2012 Jul;53(2):4.</span></strong></p>
<p style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Mom smoked while pregnant: sued for cerebral palsy &amp; injury to fetus. Case on point: Armagost v.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><strong><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">Gunderson Clinic, Inc., 2011 AP522 (5/31/2012) -WI.</span></strong></p>
<p class="MsoNormal" style="text-autospace: none;"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[No authors listed]</span></p>
<p class="MsoNormal"><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: #008100;">PMID: 22919780 </span><span style="font-size: 10.0pt; font-family: 'Arial','sans-serif'; color: black;">[PubMed - in process]</span></p>
</div>
<p>&nbsp;</p>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://cpcure.com/cerebral-palsy-research-september-2012/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
